180
An-Najah National University Faculty of Nursing Bone Mineral Density results; Estrogen, Vitamin D and other factors among woman in Nablus city– Palestine Prepared by Maryam Hajahmad Mohammad Abdell-rahman Hanaa Issa Motaz Awawda Sponsors

Acknowledgment · Web viewAcknowledgment First of all, praise and gratitude to the Almighty Allah for giving us strength and patience for finishing this project. We would like to

Embed Size (px)

Citation preview

An-Najah National UniversityFaculty of Nursing

Bone Mineral Density results; Estrogen, Vitamin D and other factors among woman in Nablus city– Palestine

Prepared by

Maryam Hajahmad Mohammad Abdell-rahman Hanaa Issa Motaz Awawda

Sponsors

Supervisor

Dr. Mariam Al-Tell

Submitted as the requirement for the final project thesis of the bachelor's

degree in nursing. Faculty of medicine and health sciences at An-Najah

National University, Nablus, Palestine.2015

اإلهداء من أعماق القلوب نوجه كلمة شكر

مشفوعة باالمتنان والتقدير إلى الجهة الداعمة

لمشروعنا التخرج

جمعية الكتاب المقدس " " الفلسطينية

الذين جادت أيديهم الكريمة بالخيروأنفسهم العظيمة

... بالبذل والعطاء إلنجاح هذا المشروع

Page 2 of 129

Table of Contents

Acknowledgment............................................................................................

Abstract..................................................................................................................

Abbreviation..........................................................................................................

OHD : Hydroxyvitamin D.....................................................................................

Definitions..............................................................................................................

Introduction...........................................................................................................

History of osteoporosis....................................................................................14

Background............................................................................................................

Bone modeling and remodeling......................................................................15

Definition of osteoporosis...............................................................................16

Osteoporosis Symptoms..................................................................................16

Diagnosis of osteoporosis................................................................................16

Bone mineral density.......................................................................................17

Laboratory tests...............................................................................................18

Risk factors of osteoporosis............................................................................18

Risk factors of osteoporosis that cannot be changed or influenced.............19

Risk factors of osteoporosis that can be changed or influenced..................20

Aims of the study...................................................................................................

Study Questions.....................................................................................................

Hypothesis..............................................................................................................

Page 3 of 129

Problem Statement................................................................................................

The significance of the study................................................................................

Literature Review..................................................................................................

Osteoporosis and Risk Factors........................................................................28

Osteoporosis and estrogen...............................................................................34

Osteoporosis and Vitamin D...........................................................................35

Bone density scan (DXA)...............................................................................37

Awareness of osteoporosis..............................................................................38

Methodology...........................................................................................................

Study design....................................................................................................41

Setting..............................................................................................................41

Population........................................................................................................41

Sample method and sample size......................................................................41

Inclusion criteria..............................................................................................42

Exclusion criteria.............................................................................................42

Data collection tools........................................................................................42

Validity and Reliability of the questionnaire..................................................43

Pilot study....................................................................................................44

Cronbach's (alpha) test.................................................................................44

Validity and reliability for DXA.....................................................................44

BMD test in little hand association.................................................................45

Vitamin D test validity and reliability.............................................................46

Validity and reliability of estrogen (Estradiol (E2)).......................................48

Filed work.......................................................................................................49

Data Analysis.........................................................................................................

Page 4 of 129

Ethical Considerations.....................................................................................51

Financial issues:..............................................................................................51

Budget.............................................................................................................51

Results.....................................................................................................................

Discussion...............................................................................................................

Conclusion..............................................................................................................

Recommendations................................................................................................100

Limitations...........................................................................................................101

References (APA style)........................................................................................102

Annex I (questionnaire)......................................................................................116

Annex II Facebook event....................................................................................122

Annex III IRB approval latter............................................................................123

Annex IV (consent form).....................................................................................124

Annex V (Approval of funding)..........................................................................125

Page 5 of 129

List of tablesPageTableNo.

18Criteria of WHO of diagnosis osteoporosis according to T-score of BMD results

Table (1.1)

22Recommendations of vitamin D according to age group to Institute of Medicine (IOM)

Table (1.2)

23Recommended daily calcium for women according to IOM are as follows

Table (1.3)

23Calcium content of different foods as (IOF) listTable (1.4)25Exercises recommendationsTable (1.5)52Values of dependent variablesTable (3.1)52Values of independent variablesTable (3.2)53BudgetTable (3.3)54Distribution of percentage of participant’s regarding to

their demographic dataTable (4.1)

55Distribution of Percentage of Participants According To Medical and Surgical History

Table (4.2)

56Distribution of percentage of participants according to their obstetrics history

Table (4.3.1)

57Distribution of percentage of participants according to their breast feeding history

Table(4.3.2)

58Distribution of percentage of participants according to their life style and nutrition

Table (4.4)

60Distribution of percentage of participants according to their physical activity

Table (4.5)

61Distribution of percentage of participants according to sun exposure

Table (4.6)

62Distribution of percentage of participants BMD of femoral and lumber results

Table (4.7)

65Distribution of participants’ percentage according to their age and BMD

Table (4.8)

66Distribution of Participants according to BMI and BMDTable(4.8)68Distribution of Participants Percentage according to

Calcium Consumption and BMDTable(4.10)

69Distribution of Participant’s Percentage according to Table (4.11)

Page 6 of 129

amount of Milk Consumption /Week and BMD71Distribution of Participants Percentage according to Dose

of Sun Exposure/min and BMDTable (4.12)

72Distribution of Participants Percentage according to Duration of Sun Exposure and BMD

Table (4.13)

73Distribution of Participants Percentage according to Number of Parity and BMD

Table(4.14)

74Distribution of participants percentage according to amount of cheese consumption per week and BMD

Table (4.15)

75Distribution of Participants Percentage according to Amount of Soft Drinks per Week and BMD

Table (4.16)

76Distribution of Participant's Percentage according to amount of Yogurt Intake Per Week and BMD

Table (4.17)

77Distribution of Participants Percentage according to Duration of Exercise in Minute and BMD

Table (4.18)

79Distribution of Participants according to Number of Smoked cigarettes and BMD

Table (4.19)

81Distribution of Participants Percentage according to Status of Menstrual Period

Table (4.20)

83Distribution of Participants Percentage according to Menopause Period and BMD

Table (4.21)

85Distribution of Participants according to Number of Breast Fed Children and BMD

Table (4.22)

87Distribution of Participants according to Family History of Osteoporosis and BMD

Table (4.23)

88Distribution of Participants according to Usage of Hormonal Tablet and BMD

Table(4.24)

89Distribution of Participant’s Percentage according to Vit D and BMD

Table (4.25)

90Distribution of participants according estrogen level among different groups and BMD

Table (4.26)

Page 7 of 129

Table of Figures

Figure 1 Correlation between age and femoral BMD………………………….63

Figure 2 Correlation between age and lumber BMD………………….……….63

Figure 3Correlation between BMI and lumber BMD………………………….64

Figure 4Distribution of Participant’s Percentage according to amount of Milk

Consumption /Week and BMD……………………………………………….. 67

Figure 5Correlation between amount of soft drinks consumption and BMD of

femoral…………………………………………………………………………72

Figure 6 Duration of exercise in minutes / day……………………………….. 75

Figure 7 Number of smoked cigarettes/day……………………………………77

Figure 8Status of period and femoral BMD…………………………………... 78

Figure 9 Status of period and lumber BMD…………………………………... 79

Figure 10Correlation between menopause period and femoral BMD…………81

Figure 11 Correlation between menopause period and BMD………………… 81

Figure 12No. of breast fed children and BMD of femoral……………………. 82

Figure 13No. of breast fed children and BMD of lumber…………………….. 83

Figure 14 Correlation between estrogen and femoral BMD…………………. 88

Figure 15correlation between estrogen and lumber BMD……………………..88

Page 8 of 129

Acknowledgment

First of all, praise and gratitude to the Almighty Allah for giving us strength and patience for finishing this project.

We would like to express our sincere gratitude for all who supported us in this project. Many thanks to our supervisor, Dr. Mariam Al-Tell for her continuous assistance and advice before and during the work. Without her guidance this study would not have been possible.

We also would like to thank Palestinian Bible Society for generous sponsorship of the project that was a success key in conducting this research. In addition, we are grateful to Little Hands Society and all the working team for their help in data collection.

Our thanks and appreciation to Dr. Eman Elshawish for her efforts in providing the necessary knowledge to conduct this research, Dean of the nursing department Dr-Aidah Alkaissi for all her continuous effort during the four years and to An-Najah National University in general.

Page 9 of 129

At the end, we are very thankful to our families and friends, who always motivate us to reach our goals

Abstract

Osteoporosis is an important health problem which affected the density and quality of

bone, characterized that the bones become fragile, brittle and more susceptible to get

fracture, also osteoporosis called as a "silent disease” without symptoms so people they

don't know that they have disease.

In addition, it was found that the prognosis of osteoporosis will increased in the

Palestine, especially among women .So, the aim of the study was to determine the

relationship between estrogen level, vitamin D and BMD and to find out other factors

affecting BMD results in Nablus city.

A descriptive quantitative design was used to achieve the aim of the study utilizing

convenience quota sampling method to select 300 women for those who attend to the Little

Hand Society in Nablus city.

A self-administered questionnaire was used to collect data and to assess other

factors, bone mineral density was evaluated using DXA devices at both side lumber and

femoral, and estrogen level for 300 women and vitamin D level for 150 women was tested

through blood sampling.

The results showed that the BMD results at femoral and lumber site were

respectively as following: normal (58.7%) (52%), osteopenia (36%) (35.7%) and

osteoporosis (5.3%) (12.3), the study also showed that there was a positive relationship

between estrogen level and BMD results .The risk factors that affecting the BMD results; age

,menopause, BMI, milk consumption, soft drinks consumption, duration of exercise, status of

menses and number of breast fed children.

Conclusion ,the osteopenia percentage was prominent and high among participants

in general, the highest percent of it was in women at age (>55) year. The normal Estrogen

serum level according to status of period were as following: (76%) of women who have

regular period, their results were (15-350) ,also (72%) of women who have irregular period

Page 10 of 129

their results were (15-350) , in addition (35%) of menopause women , their results were (less

than 10). Moreover the highest age group has deficiency in Vitamin D is (45-44)

Recommendation: further attention for women who developed osteopenia to prevent

developing osteoporosis and any consequences

Key words: osteoporosis, vitamin D, estrogen level and BMD results

Abbreviation

BMD: Bone Mineral Density

BMI: Body Mass Index

CDC: Center of Disease Control

CHD: Coronary Heart Disease

DEXA: Dual Energy X-ray Absorptiometry

DPA: Dual Photon Absorptiometry

FOOQ: Facts on Osteoporosis Quiz

HRT: Hormone Replacement Therapy

IOF: Internationals Osteoporosis Foundation

LHS: Little Hand Society

NIH: National Institute Health

NOF: National Osteoporosis Foundation

OCs: Oral Contraceptives

OHD : Hydroxyvitamin D

OP: Osteoporosis

PDEXA: Peripheral or portable Dual Energy X-ray Absorptiometry

PQCT: Peripheral Quantitative Computed Tomography

QC: Quality control

QCT: Quantitative Computed Tomography

QUS: Quantitative Ultrasound

RA: Radiographic Absorptiometry

RCT: Randomized Controlled Trials

SPA: Single Photon Absorptiometry

SXA: Single Energy X-ray Absorptiometry Page 11 of 129

WHO: World Health Organization

Definitions

Body Mass Index (BMI): a simple index of measure body fat tissue, defined as

the weight in kilograms divided by the square of the height in meters (kg/m2).

Bone Mineral Density (BMD): a test used to evaluate the density of the bone

or how tightly the bone is packed, as represented by the amount of mineral

(calcium content).

DEXA: Dual Energy X-ray Absorptiometry, is an enhanced form of x-ray

technology that is used to measure bone loss, it characterized that a quick,

painless, noninvasive and emits less radiation than a tooth x-ray test.

Estrogen level for female (not menopausal): normal value for estrogen level

in blood located between 15-350 pg/mL ,(Mayo Foundation for Medical

Education and Research,2015) .

Estrogen level for menopausal female: normal value for estrogen level in

blood <10 pg/mL, (Mayo Foundation for Medical Education and

Research,2015) .

Estrogen: is a hormone produced by the ovaries, adrenal cortex, placenta, and

male testes, it control physical changes associated with puberty.

Gravida: the number of times the woman has been pregnant.

Menopause: is a normal physiological process in women that happened when a

menstrual periods stop for 12 months between 45-55 ages

Osteopenia: Bone mineral density value located between 1 to 2.5 SD below the

young adult reference range (-1 to -2.5), (WHO, 2012).

Osteoporosis: Bone mineral density More than 2.5 SDs below the young adult

reference range (-2.5 or less) , (WHO, 2012).

Parity: the number of children previously borne

Page 12 of 129

Perimenopause: the period of a woman’s life, that makes women prepared for

transition toward permanent infertility (menopause), it can begin 8 to 10 years

before menopause

Postmenopausal: woman has experienced 12 consecutive months without

period

Vitamin D deficiency: vitamin D serum level in blood less than 19 ng/mL ,

(Mayo Foundation for Medical Education and Research. 2013) .

vitamin D Normal level : vitamin D serum level in blood located between 20-

50 ng/mL, (Mayo Foundation for Medical Education and Research. 2013) .

Vitamin D: a steroid vitamin, which promotes the intestinal absorption and

metabolism of calcium and phosphorus and plays an important role in bone

health to keep it strong. It obtained from sun exposure, food, and supplements.

Page 13 of 129

Introduction

History of osteoporosis

The history has recorded a series of discovering, developments and the

appearance of osteoporosis over the years in the majority of countries of the

world, in ancient Egyptian before 4000 years ago, "hump back" was discovered

in the most mummies due to insufficient diagnostic tool to detect early the

skeletal problems, arthritis and osteoporosis, (Osteoporosis, 2007).

Before 150 years ago, it was found a relationship between bone loss and

decrease in bone mineral density with a risk of developing hip fracture by

Astley Cooper .However, in the 1830s, the term osteoporosis "porous bone" was

pathological deemed to describe a break down human bones which were have a

large bores by the French pathologist Jean Lobstein (Grob, 1931).

In 1940, it was considered by Fuller Albright, that the woman as

consequence of postmenopausal period her bone become more fragile and low

mineral contents that make her highly risk to develop osteoporosis in this state

particularly, but the researchers were being discussed whenever that the process

of bone lose it consider to be an aging process as relation of hormonal changes

due to menopause consequences or an a pathological condition (Manring, and

Calhoun, 2011)

Page 14 of 129

Background

Bone modeling and remodeling

Bones are dynamic, growing and living tissue that supports the muscles,

protects vital internal and stores most of the body’s calcium .The bone made up

of three major components that make them flexible and strong. It consists

mainly of a protein that gives bones a flexible framework called collagen and

complex of calcium phosphate mineral that harden and strengthen the bones.

Bone also contains living cells that remove and replace weakened sections of

bone, called osteoblasts and osteoclasts, (NOF, 2014).

At 18 century, John Hunter discovered the remolding bone process,

which mean the old bone, has been destroyed and replaced by new bones of the

skeleton.(Osteoporosis, 2007).Modeling bone process indicated that the body in

the period of growing in childhood frequently build and form new bones in

every sites of the skeleton, rather than a remolding process, which continue

remove and replacement the old bones (osteoclasts)in all life periods with

format new bone (osteoblasts).

During the childhood and adolescent periods, the body continuously

grow and become strong and tall due to a continuous process of building and

form a new bone more than destroying and breakdown the bone until it reaches

the peak bone mass or maximum amount of bone which mean bone at the end

level of maturation and usually happened at 20 year, around the third decade of

life the bone strength and tissue bone contents effected by his /her sex ,genetic

factors ,environmental factors, lifestyle including physical activity, nutrition and

health status. So before discovering the remodeling process it was difficult to

Page 15 of 129

recognize the osteoporosis, as this process play a critical role in determine the

bone changes in adults and abnormalities in bone mineral density,(Henry,1918).

Definition of osteoporosis

Osteoporosis is an important health problem which affected the density

and quality of bone, characterized that the bone become fragile, brittle and more

susceptible to get fracture due to abnormal loss in bone minerals which lead to

decrease the density in the bone thickness so the bone become thinner which

known as “fragile bone” and more porous,(IOF,2015). In 1994, the

Osteoporosis is defined by World health organization (WHO) as “A disease

characterized by bone density 2.5 standard deviations below the mean for young

white adult women at lumbar spine, femoral neck or forearm a consequent

increase in fracture risk” (WHO, 1994), also the osteoporosis was defined as

“skeletal disorder with process of micro architecture weakening of the bone

which lead to increase the fracture onset”, (Copenhagen Consensus Conference,

1990).

Osteoporosis Symptoms

Unfortunately, people don't aware that they have osteoporosis due to the

bone loss does not reflect by symptoms until he/she suffer from a serious

fracture in hip, back, wrist or vertebrae due to sudden accident or fall, so, the

osteoporosis called as a " silent disease”. The most symptoms is a fractures,

according to the location of the fracture it cause neck and muscle pain also bone

tenderness in more than place and back pain in the lower and upper regions of

the back is common symptoms of osteoporosis individuals .In addition, may

developed spinal deformities like kyphosis or loss of height about two inches

because of compression on the spine cord due to the fractures. Therefore, the

doctors and Professional if any one comes of these symptoms it would evaluate

them of osteoporosis, (Krucik, 2014).

Page 16 of 129

Diagnosis of osteoporosis

During the 1960s, it was developed a diagnostic devices for detecting

bone loss and the status of the bone, including densitometers, which can

determine bone density by measuring changes in the absorption of energy

passing through bones in the hand, spine, hip, or other body part to help

detecting early the osteoporosis,(Osteoporosis, 2007).

Osteoporosis is diagnosed by taking information about medical history

about risk factor include age, gender, menopause age, any past or current

fracture, family history of osteoporosis, smoking, nutrition and diet habits

include calcium and vitamin D intake level, physical activity or having irregular

periods for premenopausal women with a physical examination like make X-ray

or measure height and some specific tests for bone lose like Vitamin D and

estrogen, (Wilkins, 2007).

Bone mineral density

Is a test used to evaluate the density of the bone or how tightly the bone is

packed in the spine, hip, wrist, finger or heel but the bones in the lower spine

and hip is often measured because there are highest suspected to get fracture . In

addition, it used to measure the amounts of minerals like calcium in an area of

bone to determine the strength of bone and the risk of developing osteoporosis

or fractures. Many techniques are available to assess BMD at multiple sites

including (Health wise, 2014):

Dual Energy X-ray Absorptiometry (DEXA)

Peripheral or portable Dual Energy X-ray Absorptiometry(pDEXA)

Single Energy X-ray Absorptiometry(SXA)

Peripheral Quantitative Computed Tomography(pQCT)

Radiographic Absorptiometry(RA)

Page 17 of 129

Quantitative Computed Tomography(QCT)

Quantitative Ultrasound (QUS)

The most common method of measuring bone density in the spine and

hip is a ‘Dual-energy X-ray Absorptiometry’ (DXA) scan to study the

effectiveness of treatment or any change in bone density happened overall

times. It characterized that a quick, painless, noninvasive and emits less

radiation than a tooth x-ray test to measure the bone density. DEXA it described

as "the gold standard diagnostic tool for osteoporosis" (Hernlund et al, 2013),

but because of limited availability of BMD technology in some communities

and cost considerations, it has been focused on the specific group who are high

risk for low BMD.

Table 1Criteria of WHO of diagnosis osteoporosis according to T-score of BMD results

Bone DensityT-score

Normal Less than 1 standard deviation (SD) below the young adult reference range (more than -1)

Osteopenia 1 to 2.5 SD below the young adult reference range (-1 to -2.5)Osteoporosis More than 2.5 SDs below the young adult reference range (-2.5 or less)

(WHO, 2012)

Laboratory tests

It was discovered before recent year’s biochemical markers of bone

turnover. Some of these tests can be used to detect the loss of bone and monitor

the effectiveness of DXA devices for hormone replacement therapy (HRT) like

Vitamin D and Estradiol tests, (NOF, 2014).

Risk factors of osteoporosis

As well-known previously that the risk factor is as a variable that is

related to an increased possibility of occurrence of a disease. Therefore, there Page 18 of 129

are certain risk factors associated in development of osteoporosis and contribute

to an individual's risk of developing the disease. some of these factors cannot be

changed but others risk factors are capable to be changed, so identified these

risk factors it's important to detect and understanding the pathophysiology of the

disorder and contribute in treatment and in preventive strategies of develop

osteoporosis, the main risk factors are:

Risk factors of osteoporosis that cannot be changed or influenced

1. Gender

The women are much more likely to develop osteoporosis than the men

due to changes that happen with menopause that make the bone lose faster than

men and there is no period of rapid hormonal change and accompanying rapid

bone loss in the men, in addition, differences in bone geometry and remodeling

also contribute to the lower rate of fractures in men .However, the statics show

in America that about 80% of 10 million Americans with osteoporosis were

women,(NOF,2012).

2. Age

The risk of osteoporosis increased when the age exceed 40 year old or

more comparing with younger one ,because the bone mass density declines due

to bone breakdown exceeding bone building at aging period (reached peak pone

pass as mentioned above), (Zimmerman and Snow, 2012).

3. Heredity (family history)

Any family history of osteoporosis, brittle bones, Kyphosis, fractures,

Dowager’s hump, all of this condition has sensitive predictor of osteoporosis

risk. Also having a parent or sibling, sisters and mothers who had osteoporosis,

Page 19 of 129

have positive correlation of developing osteoporosis (Soroko et al 1994).In

addition, studies identified over 60 genetic markers associated with bone

density and susceptibility to fractures due to osteoporosis,(CDC, 2015).

4. Menopause

Menopause is a normal physiological process in women that happened

when a menstrual periods stop for 12 months between 45-55 ages which the

ovaries slow down their functions and reduce production of estrogen and

progesterone much less amounts . When the women entered this period it will

potential start lose bone, which will make her at greater risk of developing

osteoporosis. It was conducted in UK that premature menopause (before 50

year) is risk factor for osteoporosis in the future, (Family health guide, 2012).

5. Null parity, pregnancy and lactation

The changes that occur in women during pregnancy and breastfeeding

have effects on her bones, which change the level of hormones of progesterone

and estrogen and decrease calcium absorption in the bone if the women did not

received enough calcium during pregnancy, she will developed osteoporosis. In

addition, women at risk about 3-5% of lose her bone during breastfeeding due to

growing of baby which depends on women calcium, this influenced by the

periods of breastfeeding, (NIH, 2015).

Regardless of these changes, the pregnancy and lactation may have

protective effect on bone by enhance the strength of bone bearing in women

bones, (Salari and Abdollahi, 2014).About the null parity, the studies showed

that null parity is an established risk factor for osteoporosis, which is correlated

with increased risk of fracture and decreased BMD,(Hillier et al, 2003).

Page 20 of 129

Risk factors of osteoporosis that can be changed or influenced

1. Smoking

For previous decades, smoking was identified as a significant risk factor

for osteoporosis due to the relationship between cigarette smoking and decrease

in BMD results .As nicotine and free radicals that release from cigarette, it

damage the osteoblasts, (Davis, 2009).

Smoking effects is influenced by several factors in women, in smoked

woman who their aged between 40-50 are prone to develop osteoporosis more

quickly than other women due to rapid loss in bone as a result of decrease in

estrogen level in this period and decrease in calcium absorption in the bone

which lead to fragile bone then become susceptible to be fractured, (Whitcomb,

2010).

2. Weight

The facts indicate that people with low body weight are more susceptible

to have less BMD and increased risk of have osteoporosis than heavier people

weight as a result of more mass of bone make the bone more strong, so, body

mass index (BMI) is an important indicator for bone mineral density, In 1999 by

Ravan, it showed that people with low BMI (under 18.5 kg/m2) have a two-fold

greater risk of bone loss comparing with those people with normal or highest

BMI,(Ravan et al, 1999) .

3. Vitamin D

As the studies showed that about 99% of vitamin D found mainly in

bones and teeth, (NOF,2012), Vitamin D plays an important role in bone health

to keep it strong. By regulate the absorption of bone calcium from the intestine Page 21 of 129

and kidney and maintain it within normal level in the blood, (Davidson

2003).The main source of vitamin D intake is fortified milk and cereal, egg

yolks and fatty fish, it was found that 25% daily value(DV) in milk products

contain about 100IU of vitamin D.

Table 2 Recommendations of vitamin D according to age group to Institute of Medicine (IOM)

Age group RecommendationInfants 0-12 months 400 International Units-IU/dayWomen and men under 50 years 400-800 IU/dayAge 50 and older 800-1,000 IU/daySafe upper limit of vitamin D for adults

4,000 IU/day

(IOF, 2012)

It was found that Serum 25-hydroxyvitamin D levels dropped as age

increased in both male and female (CDC, 2012) and about 3% of women who

had hip fracture have vitamin D deficiency, (American College of

Rheumatology Task Force on Osteoporosis Guidelines 1996).So, it considered

that people who have high level of vitamin D in their blood their bone are

strong and have less chance to get fracture or to develop osteoporosis

comparing with those with low level of vitamin D, (Bischoff, 2012).

Also about the association between sunshine and vitamin D, the

researcher found that people in the winter months have less level of vitamin D

in relation to other times of the year, so low amounts of vitamin d in the blood

with other risk factors of osteoporosis make those people prone to get a fragile

bone and developed osteoporosis, (Avenell, Gillespie, Gillespie LD and

O’connell, 2005).

Page 22 of 129

4. Supplements of vitamin D

The benefit of vitamin D supplements is not clear yet because the

researcher's results are based on several factors like:

The form of vitamin d supplements type (tablets or injection).

Amount of vitamin D, which take by people.

The duration of vitamin d taken (every day, day other day).

Age of the people who take the supplements.

Taken the supplements along with other like calcium or not.

Therefore, some people the effect of these supplements on them decrease

risk of get fragile bone, but in some groups their effects does not appear. The

people who consider to be important one of get these supplements who are low

body weight and those who live in nursing home, in addition, some studies

showed that to relief osteoporosis and avoid destroyed bones, it may be most

benefit to take both calcium and vitamin D supplements together ,(Avenell, et

al.,2005).

5. Calcium intake

Calcium is mineral that associated with vitamin D and other minerals to form

the hard crystals that give the bones their strength and structure and to prevent

from bone problems (osteoporosis), (Chan and KO 2006).

The amount of calcium different among people need depends on age and

sex. The highest group need requirements of calcium are the teenagers due to

rapid growth (Specker and Binkley, 2003) and in the advanced age, the ability

of calcium absorption in the bone become is less, which requires getting

adequate amount of calcium in these groups, (Chapuy et al., 1992).

Page 23 of 129

Women Age Recommended daily calcium (mg/day)19 - 50 years 1000Post-menopause (51+ years) 1200During pregnancy/lactation 14-18 years old 1300During pregnancy/lactation 19-50 years old 1000

Table 3Recommended daily calcium for women according to IOM are as follows

(IOF, 2015)

Table 4Calcium content of different foods as (IOF) list

Food Serving size Calcium (mg)Sheep milk 200 ml 380Milk, whole 200m 236Milk, semi-skimmed 200ml 240Milk skimmed 20ml 244Yoghurt, natural 150g 207Hard white cheese 30g 240

(IOF, 2015)

6. Exposure to sunlight

From the past, it was found that sunshine is the main source of vitamin D

which is made by exposed to ultraviolet B light emitted by the sunshine and

then transported to the liver and converted to 25-hydroxyvitamin D, (CDC,

2012). For children and adults, the exposure of the hands and face to the sun for

10 to 15 minutes per day is usually sufficient to get optimal Vitamin

D(IOF,2015) ,but it differs among people based on : (vitamin D council,2010) .

The amount of skin exposed, the most of vitamin D would be achieved

when expose a large area of the skin, such as the back or if exposed the

all skin body to the sun it produce more of vitamin D .

Page 24 of 129

Time of the day, it preferably to expose to the sun during the middle of

the day for optimal vitamin D .

The place of living, people who lived closed to the equator it easier for

them to produce vitamin D from sunlight all year round.

Current season , in the summer a large amount of vitamin D will produce

in the skin more than the sunlight’s in winter

The type and color of the skin, it was found that whitish skins make

vitamin D more quickly than darker skins.

Page 25 of 129

7. Exercises

A regular physical activity and exercise plays an important role in

maintaining, building a healthy and strong bones, keep BMD within normal

range and delay as possible as can a decrease in BMD range because of

osteoporosis (Shackelford, LeBlanc and Driscoll, 2004).Effectiveness of

exercise is determined by frequency, duration and type of the exercise (IOF,

2015), as following:

(Table5)Exercises performance recommendationsAge group Duration per minutes Duration time in the weekChildren and youth aged 5–17

60 minutes 3 times per week

Adults aged 18–64

150 minutes of moderate-intensity aerobic physical activityOr75 minutes of vigorous-intensity aerobic physical activity

2 times per week

Adults aged 65 years and above

150 minutes of moderate-intensity aerobic physical activityOr75 minutes of vigorous-intensity aerobic physical activity

2 times per week

(WHO, 2012)

Page 26 of 129

Aims of the study

The overall aim of the study is to determine the relationship between

estrogen level, vitamin D and BMD and others factors among female in Nablus

city. The specific objectives are:

1. To find out estrogen serum level in blood

2. To fund out vitamin D serum level in blood

3. To determine different results of BMD by device (DXA) among different

age groups.

4. To find the relationship between estrogen level, Vitamin D and the BMD

results in relation to their groups and other variables

5. To determine the risk factors that associated in developed osteoporosis in

theses ages

6. To estimate the incidence rate of osteoporosis

Study Questions

1- Is there a relationship between estrogen level and BMD results among

women?

2- Is there a relationship between vitamin D and BMD results among

women?

3- What are the factors affecting the BMD results?

Hypothesis

There is a relationship between estrogen level and BMD results.

There is a relationship between vitamin D and BMD results.

Page 27 of 129

Problem Statement

As mention in the previous studies that the osteoporosis considered as

'silent disease' without symptoms so people they don't know that they have the

disease and it was found that the prognosis of osteoporosis will increased in the

Palestine (PSBC,2012) especially among women. Therefore, this study focused

on measuring the BMD among women, which consider as stronger predictor of

osteoporosis, also determine the major risk factors that affect the heath of bone

for them, and find if there is a relationship between the vitamin D, estrogen and

BMD, all these aims will help in increasing the awareness of the consequence of

osteoporosis ,and improve the health strategies in the primary health care in

Palestine by provide the main diagnostic tool (DEXA) for early detecting for

osteoporosis

The significance of the study

People used to think that the osteoporosis was part of aging, today, by

knowing the risk factors of osteoporosis in woman, it is very important to detect

early who are at high risk for developing it. Early detection will help in

prevention related complication and the risk of fractures.

Scientifically, there is never too young or too old to take care of bones,

good lifestyle habits and good consumption of food can help to protect the

bones and decrease the chance of getting osteoporosis.

.

Page 28 of 129

Literature Review

There are many researches and studies conducted to evaluate the BMD

vitamin D, estrogen and other factors among women, regarding the results, there

is a variation between it according to the participant’s age, gender, and life

styles in theirs countries.

Osteoporosis and Risk Factors

In the period from 2000 to 2010, a retrospective population-based cohort

study was conducted to explore the risk of coronary heart disease (CHD) within

an Asian population in relation to osteoporosis. The sample consisted of 19,456

patients aged 45 years and older with no history of CHD and had a diagnosis of

osteoporosis were identified as the osteoporosis cohort. Moreover, the

comparison cohort group was randomly selected. The findings revealed that the

incidence of CHD was 23.5 per 1000 person-years for the osteoporosis cohort,

while it was 16.7 for the comparison cohort with a significant relationship

between osteoporosis and coronary heart disease in Asian population, (Chen,

Lin & Kao, 2015).

Another quantitative study conducted in Brazil as a transversal

retrospective approach between the period March 2013 and June 2013 with total

of 107 women. The purpose of the research was to recognize the risk factors

that associated with  osteoporosis ,the results considered that smoking, low

physical activity and caffeine intake as a risk factors, while the absence of

alcoholism and soda intake were categorized under protective factors for the

disease ,(Costa et al ., 2015 ).

In Poland, a research study analyzed the consumption of dairy products

and dietary calcium in a sample of 712 polish women who divided into two

groups of women. In the 1st group, the result showed that ages older than 49

Page 29 of 129

years and lack of menstrual cycle is associated with low BMD (below −1 SD);

the dietary calcium intake by women in this group was 459 mg/day. In the 2nd

group, the analysis showed that the regular BMD (over/equal to −1 SD) was

related to women who were younger than 50 years, presence of menstrual cycle

and a higher consumption of dairy products , the results also showed that 67%

amount in the calcium was found in milk, cheese and yogurt, (Wadolowska et

al., 2013) .

A cross-sectional study in Jordan was conducted in 2003 for Jordanian

women in Amman city to assess the association of obstetric issues (pregnancy

and lactation), and other menstrual history factors with low (BMD). According

to WHO criteria, the findings showed that 119 woman (29.6%) were having

osteoporosis, 176 (43.8%) having osteopenia, and 107 (26.6%) with normal

BMD. However, it was found that years of menstruation, age at menopause,

days of menstrual cycle, number of pregnancies, and duration of hormone

replacement therapy (HRT) were positively correlated with BMD, but there was

no correlation with number of children (live births) and frequency of lactations

was only evident at femoral neck. Moreover, the independent risk factors after

adjustment for age and BMI were the smoked woman for more 25

cigarettes/day, postmenopausal women irrespective of HRT use, menopausal

years of ≥5 year intervals, natural early menopause, rheumatoid arthritis,

osteoarthritis, hypertension, and thyroid replacement therapy. In addition, ever -

lactation, frequent lactation of 4 or more times, duration of lactation for 1–6

months and clinical hyperthyroidism were significant protective factors.

Although a gravidity, menstrual flow pattern, family history of osteoporosis,

clinical hypothyroidism, and corticosteroids therapy were not independent

predictors of osteoporosis was found among this population. Therefore, the

finding was showed that the prevalence of osteoporosis among the Jordanian

female population is extremely high, and is even found in younger age,

(Shilbayeh, 2003).

Page 30 of 129

In Davao, Philippines, Cross-sectional study was used among 905 women

to assess the occurrence of osteoporosis among post-menopausal women

dwelling in an urban community of the Philippines and to explore the risk

factors for osteoporosis using a quantitative ultrasonic bone densitometer. The

statics showed that 19.8% of osteoporosis was in postmenopausal women. In

addition, it showed that the body weight could be considered as changeable risk

factor for osteoporosis in postmenopausal women group, (Miura, Saavedra and

Yamamoto,2008).

In Korea, a study conducted in period 2008-2011to assess and detect

gender differences in factors associated with prevalence, awareness, and

treatment of osteoporosis of 3,071 men and 3,635 women. The osteoporosis

rates was 7.0% in men while 40.1% in women. Higher incidence of

osteoporosis was found among participants who were older, at lower

socioeconomic levels, with lower body mass index and shorter height in both

genders, and among women with non-hormonal replacement therapy. In

addition, it found that the osteoporosis occur more in female rather male, (Kim,

Kim & Cho, 2015).

In Sweden, randomized controlled trials (RCT) study was used

to evaluate the significance of exercise as a strategy to improve peak bone mass,

including some parts of nutrition. The study showed that “exercise during

growth seems to enhance the building of a stronger skeleton through a higher

peak bone mass and a larger bone size”, (Karlsson, Nordqvist and Karlsson C,

2008).

A cross sectional study of bone density dimensions was carried out in

British women to asses possible risk factors for bone density in these women by

DXA for 284 women aged between 21 to 68 years. The results showed that the

Page 31 of 129

bone density was affected by increasing age related to menopause series. Other

factors affected diminishing bone density, and hence increasing risk for

osteoporosis, such as low body weight, alcohol and cigarette consumption, null

parity, lack of preceding use of oral contraceptives, and lack of regular exercise.

In addition, the study suggested for continuous measuring the bone mineral

density by DXA to detect early women who have high risk of developing

osteoporosis, (Stevenson et al., 1989).

In New York USA, a study conducted in 1985 to compare between 58

women with postmenopausal osteoporosis with 58 age matched normal women.

The finding showed that women who had diagnosis with osteoporosis have

lower total body calcium levels and BMD, and those who had an earlier

menopause, smoked cigarettes more, and had breast-fed less often developed

osteoporosis ,they also had lower levels of estrogen, estradiol, and testosterone

and reduced levels of 25-hydroxyvitamin D . That suggest these factors

considered modifiable risk factor for developing osteoporosis, (John et al.,

1985).

In Finland, epidemiologic study conducted in 1994 to assess the special

effects of menopause and certain behavioral risk factors on (BMD) by

measuring the BMD by DXA for Spinal and femoral neck for 1600

premenopausal women aged 48–59 years. The result was considered that the

menopause had a main effect on BMD. Postmenopausal women had pointedly

lower BMD in both spine and femoral neck as related with premenopausal

women. Multiple factors also contributed in decreasing the BMD like weight,

menopausal status and age, moreover, physical activity was found to be an

important predictor of lowering the BMD, (Kröger et al., 1994).

A study was conducted in 2001 to measure the relation between use of

oral contraceptives (OCs) and effects on bone mineral density (BMD) for

Page 32 of 129

women who aged 25–45 years. The women have been join up to two groups

one group included women who have been use OC (≥ 3 months) and other

group were women who have certainly not used OC (0 to < 3 months). The

findings showed that women who had ever and those who had never used OCs

showed no variances in age, age at menarche, parity, present calcium intake,

exercise, body mass index (BMI), education and past irregular cycles or

amenorrhea. Moreover, BMD values showed lower in OC group and the mean

length of use was 6.8 years, (Prior et al, 2001).

A cross sectional retrospective epidemiologic study was conducted in

1991 to determine risk factors for low bone mineral density (BMD) for 2297

women 76% of whom were postmenopausal. The women were classified into a

BMD category based on the range of BMD measurements and other data

(history of oral contraceptive use).The finding indicated that menopause,

increasing age and years since menopause, and decreasing body mass index

were associated with low BMD. In addition, the history of oral contraceptive

use was protective against low BMD and increasing duration of use was more

protective. The most important point indicated by the results that, the use of use

of oral contraceptive agents, was found to be associated with higher levels of

BMD and that the degree of protection from lower BMD is related to duration

of exposure”, ( Kleerekoper et al., 1991).

In United Kingdom, a study conducted in 1994 to define the relationship

between parity and bone mineral density in middle-aged women. 825 women

were chosen to participate. It was establish that the mean of BMD was

significantly higher at all sites (the spine, hip and Ward's triangle) among the

parous women, it was indicated that there was an increase by 1% in BMD per

each live birth, which revealed a positive between parity and bone mass,

( Murphy et al.,1994 ).

Page 33 of 129

A cross sectional study conducted in United Kingdom in 1994 to study

the effects of milk intake on recent bone mineral density at the hip and spine for

284 women aged 44-74 year. The women were categorized their average milk

consumption to their age into up to age 25, from age 25-44, and from age 44 to

the present time. The finding showed that the average of milk consumption

wasa significant independent predictor of bone mineral density at both hip and

spine in woman who their age was up to 25. Nevertheless, the women who was

their age 25-44 year and from age 44 year has not statistically important,

(Murphy et al., 1994).

In turkey 2013, a study explored the effects of parity and age at first

pregnancy and breast-feeding and the interval of BF for total and per child on

postmenopausal osteoporosis among 542 women who were divided to 2 groups

based on the presence (osteoporosis group) or absence of osteoporosis (non-

osteoporotic group).The finding showed that the osteoporosis group had

pointedly lower parity compared to non-osteoporosis group. Prolonged breast-

feeding period per child > 1 year is the greatest risk factor for osteoporosis

independent of first breast-feeding age. However, high parity has a defensive

effect, (Okyaya et al., 2013).

In Asian countries, a study conducted in 2008 to evaluate the risk factors

for osteoporosis in postmenopausal women from selected BMD centers in Iran

and India. The sample sizes from Iran was 363 subjects (178) of them

osteoporosis and the rest of them (185) normal, and from India a total of 354

subjects (203) osteoporotic and (151) normal. They separated into two groups;

case group (postmenopausal osteoporotic women bone density higher than 2.5)

and control group (postmenopausal women with normal bone density). The

results showed the risk factors in Iran and India respectively by odds ratio were

as duration of menopause greater than 5 years: (2.2) (1.4), menarche age (after

14 years): (1.9) (1.6), menopause age (before 45 years): (1.1) (2), parity more

than 3: (1.1) (1), bone and joint problem (2.3) (2.2).However, calcium

Page 34 of 129

supplementation more than 1 year, exercises, regular consumption of cheese,

milk and HRT were shown as defending factors in India, (Keramat et al., 2008).

In India, a study was conducted in 2013 to monitor the bone status

osteopenia and osteoporosis for whom their age were more than 35 years, of158

women .The results showed that there was statistically important connection

between age group and the incidence of osteopenia and osteoporosis. There was

a negative association between age of the women and BMD. As well age,

gravida status and menopausal status have negative correlation with BMD while

there was a positive association with physically active lifestyle, (Agrawala and

Vermab, 2013).

Osteoporosis and estrogen

In USA California, study conducted in November 1990 to examine the

prevalence and determinants of estrogen replacement therapy in 9704 non-black

women, age ≥65 years. The finding indicated that the prevalence of estrogen

hormone uses among woman who have been diagnosed osteoporosis was 24%

of participants, and the uses of estrogen hormone replacement therapy was

common among women who had higher levels of education and who were less

obese,(Cauley et al., 1990).

In USA, a study conducted during 1988-1994 to estimate osteoporosis

prevalence based on BMD. The findings indicated that most estrogen-deficient

women in the United States who had femoral osteoporosis were ignorant of

having this condition, (CDC, 1998).

In Japan, other study published in 2013 to determine the effect of

estrogens on the development of immobilization osteoporosis by measurement

of cortical thickness of the femurs. The findings showed that administration of

Page 35 of 129

conjugated estrogens significantly protected against the decrease in the bone

density and the cortical wideness of the femurs, (Orimo et al., 1970).

In United States, a double blind, randomized study conducted in 1992 to

estimate the acceptance and efficiency of transdermal estrogen for women with

established postmenopausal osteoporosis and vertebral fractures. 75women

were chosen, their age was between 47 to 75 years. After the measurement, the

results showed that the group who took the estrogen had an increased or steady-

state bone mineral density at the lumbar spine, femoral trochanter and mid

radius compared with placebo groups, which mean that the estrogen therapy

have the effectiveness treatment in postmenopausal women with well-known of

osteoporosis ,( Lufkin et al., 1992) .

In Romania, a cross-sectional study conducted in 2012 to define the

association between (BMD) in pre and postmenopausal women and estrogen

levels. The women divided for six groups composed of 8- 15 pre and

postmenopausal fit volunteers with dissimilar weights. The result foundthat the

BMD in postmenopausal women were lower than in premenopausal women

regardless of body weight. Estradiol and estrogen were positively associated

with bone mass in premenopausal women, but not in postmenopausal women,

(Corina, Vulpoi and Branisteanu, 2012).

In morocco, a study conducted from period between October 2012 to

April 2013 among menopausal women aged 50 years old and over. 207 women

who had no previous diagnosis of osteoporosis joined the study to define the

relationship of sex hormones, bone remodeling indicators and vitamin D levels

with (BMD). The result showed the significance of postmenopausal estrogen in

the bone loss and the pathogenesis of osteoporosis in old women,(El Maataoui

et al., 2015).

Page 36 of 129

Osteoporosis and Vitamin D

In Australia, a random sample of women (n=861) aged 20-92 was select

for cross sectional study to evaluate vitamin D intake and casual exposure to

sunshine. The result showed that the participant’s intake of vitamin D was 1.2

micro g/day. However, the intake of vitamin D supplements by participants

have been increased from 7.9% to 8.1%, also it was observed that there was

relationship between serum 25 OH D levels and the seasons, they found that

prevalence of low concentrations of serum 25 OH D were most common in

winter, (Pasco et al., 2001).

In Poland, a cross-sectional study based on the regional urban non-

institutionalized sample of 107 postmenopausal  women in the age range of 51-

83 years to evaluate the seasonal occurrence of inadequate (insufficient or

deficient) serum vitamin D levels in women who screened for osteoporosis. The

prevalence of vitamin D deficiency and insufficiency were shown in spring

(54%) and (32%), in summer (46%) and (46%), in autumn (67%) and (27%),

and in winter (61%) and (22%), respectively, (Stolarczyk et al., 2014).

In China, a study occurred to define the prevalence of vitamin D

insufficiency and its risk factors in addition to its association with osteoporosis

in a Chinese people. Random method was used to select 2942 participants of

both gender with the age group of 40-75. The analysis showed that vitamin D

deficiency(25(OH)D levels < 20 ng/mL) prevalence was 75.2% in the

participants with more occurrence in women (79.7%) than men (64%) .The

analysis also indicated that the significant predictors of vitamin D deficiency

included coronary heart disease, obesity, dyslipidemia, older age, female sex,

and smoking. However, tea intake, moderate physical activity, milk intake,

vitamin D supplementation and sun exposure were considering protective

factors. The major point in this study indicated that reduced in 25(OH) D levels

were not primary related with an increased osteoporosis risk,(Zhen et al., 2015).

Page 37 of 129

In Japan, a study conducted in 2003 to assess the effectiveness of sunlight

exposure in increasing serum 25-OH D, in dropping the severity of osteoporosis

in (BMD) for 258 participants which divided to 2 groups, 129 received regular

sunlight exposure for 12 months and the remaining 129 (sunlight-deprived) did

not. The results showed that in the sunlight-exposed group the BMD increased

by 3.1% and decreased by 3.3% in the sunlight-deprived group. Moreover, 25-

OH D level increased by fourfold in the sunlight-exposed group which mean

that the sunlight exposure can increase the BMD of vitamin D-deficient bone by

increasing 25-OH D concentration, (Sato et al., 2003).

Bone density scan (DXA)

In Pakistan, observational study was designed to measure efficacy of

DEXA procedure in early detection of osteoporosis with age group 30-60 years

among female and male. The study conducted from November 2010 to October

2013. The DEXA results were normal among male about (39.10%) and among

women (23.50%) and about (45.60%) of female there DEXA result indicated

for osteopenia and (47.80%) in male, however, the results of osteoporosis

showed a significant increase in women (30.90%) and (13%) in male who have

osteoporosis, in addition, it showed that In urban areas the normal results were

(23%), osteopenia (46.50%) and osteoporosis (30.50%) In rural areas, normal

(28.70%), osteopenia (43.70%) and osteoporosis (27.60%), (Makhdoom et al.,

2014).

A study conducted in the department of family medicine to screen BMD

testing interval which indicated for estimated time for women who make the

transition to osteoporosis before have any clinical risk factors, among 4957

women who were with normal BMD or osteopenia and with no history of hip or

clinical vertebral fracture or treatment for osteoporosis their ages was 65 years

or older were would be followed prospectively for up to 15 years .The finding

Page 38 of 129

indicated according to interval test ,that osteoporosis would develop in less than

10% of older women (more than 65 years) and for postmenopausal women it

would develop osteoporosis approximately in 15 years, in 5 years for women

with moderate osteopenia, and in 1 year for women with advanced osteopenia,

(Gourlay et al., 2012 ).

A prospective study conducted in 2010 to compare the measurements of

osteoporosis in patients with femoral neck fractures by using the histological

method of diagnosis to the same patients with DEXA, The results showed that

the DEXA detected 88.2% of possible cases of osteoporosis, but the specificity

of this diagnostic tool was 62.5% .However, The parameters of osteoporosis by

histological histomorphometric were 68% of patients with the femoral neck

fracture ,the important point that covering in this study was indicated that the

DEXA could be used as diagnostic tool for osteoporosis but less efficient than

the histological histomorphometric method and the DEXA is enough as a

diagnostic tool to detect osteoporosis in one place (lumber femoral) because

there is no difference in the mean between the femoral DEXA and lumber

DEXA (mean=zero), (Humadi, Alhadithi and Alkudiari SI, 2010 ).

Other study conducted in 2002 to assess the precision, sensitivity, and

specificity of dual-energy X-ray absorptiometry (DXA) scanner applied to 202

women there aged was 55 by using World Health Organization (WHO) criterion

for defining osteoporosis. The result showed that the specificity of DEXA to

identify patients with osteoporosis at total hip, femoral neck, spine, or any of

these axial sites was excellent (97.0%, 97.0%, 96.5%, and 97.1%, respectively);

but the sensitivity was poor (58.8%, 36.4%, 21.8%, and 20.3%, respectively).

So The WHO criterion is not appropriate for DXA, (Pacheco et al., 2002).

Awareness of osteoporosis

In Nanjing, People’s Republic of China, study conducted to evaluate the

level of awareness of osteoporosis. Questionnaire, was given to 9983 men and

Page 39 of 129

women, their aged was 40 years. The results showed that Osteoporosis was

“silent disease” and was not widely recognized in the community, which would

account for why only 30.7% of their study population had heard of osteoporosis.

In addition, they found that 52.9% of the subjects drink milk, 16.0% took

calcium, 7.1% took vitamin D, and 47.2% were performing regular physical

activity, (Xu et al., 2011).

In Egypt, a study conducted to assess knowledge about osteoporosis (OP)

among 532 women aged more than 40 years, by answering the questionnaire.

The results showed the majority of women (95.1%) reported that were familiar

with osteoporosis and this knowledge of osteoporosis was associated with the

level of education and employment status of the participant woman, (Eltawab et

al., 2015).

In southeastern Poland, a group of 300 women aged 45-65 have been

selected to assess their level of knowledge in the pre- and

postmenopausal period about the prevention of osteoporosis. The results

showed that the women have an average level of knowledge about the role of

physical activity in the prevention of osteoporosis. Also it showed a low level of

knowledge of these women about well-balanced diet rich in calcium, and also it

showed that the socio-demographic factors and lifestyle influenced the level of

this knowledge, (Janiszewska et al., 2015).

In USA, a study focused on the level of awareness and knowledge of

osteoporosis but in the adolescent (209 =n) in high school, the mean of

knowledge was 33.1615 and about 75% of participants said that the information

was received from their family and the school role in providing information

about osteoporosis was slight ,(Khorsandi, Hasanzadeh and Ghobadzadeh,

2012).

Page 40 of 129

In USA, a study with a convenience sample of 162 undergraduate

students’ in two groups conducted in 2015 to describe awareness of

osteoporosis- risk factors and preventative behaviors (calcium intake and

exercise) among undergraduate students’ and determine differences in responses

between gender, and student athletes vs. non-athletes. The result showed that

the participant did not have enough experience or knowledge about osteoporosis

risk factors, (Babatunde, Brinkley and Brenda, 2015).

In Israel, a cross-sectional research design study was used to assess

knowledge and attitudes regarding osteoporosis among nurses (n=158)by using

Facts on Osteoporosis Quiz (FOOQ).The results showed that the nursing

knowledge about osteoporosis, prevention and treatment it considered to be

moderate according to score of(FOOQ) which was the average 17 out of 24

scales,(Vered et al., 2008).

In the North West of Ireland, quantitative, descriptive survey was used to

assess the current knowledge of osteoporosis between 128 nurse and midwife.

The finding showed that the nurses and midwife have high level of knowledge

about risk factors .However; the midwives have the highest level of knowledge,

(Hannon and Murphy, 2007).

Page 41 of 129

Methodology

Study design

A quantitative study have been used to assess the relation between BMD,

vitamin D and estrogen hormone among women in Nablus city , started in

August and end in November 2015 .

Setting

The study was conducted in LHS (Little Hand Society)in Nablus, it was

bullied in 1996 in to contribute in improvement of health conditions of

populations under the principle of health for all Palestinian women , it provide

many services for women include gynecological and obstetric mini clinic, also it

have a pediatric clinic, orthopedic doctor and DXA (dual energy X-ray

absorptiometry) device that use to measure the bone mineral density. A

laboratory services also was provide there. In addition, the funder suggested

working with them according to their services and due to financial issues. That

is why this association is very suitable for this study.

Population

The population of the study was all women who live in Nablus city that

composed about (52%) of all population (PCBS, 2013).

Sample method and sample size

A quota convenience method was used, 300 women were included

according to previous studies.

Participants were divided into three groups each group consisted of 100 women

start with age 35 as following:

1. Women who their ages between (35-44) year.

2. Women who their ages between (45-54) year.

3. Women who their ages above than 55 year.

Page 42 of 129

The sample has been collected conveniently according to the inclusion

criteria, after reaching the participant in the society.

It was proposed to use simple random method (every other woman) to

select the women, but it was noted during piloting that it was unethical to

return woman who came to the society to do the tests that was advertised

through face book of the society and students.

Inclusion criteria

1) Women participants

2) The age above 35 years

Exclusion criteria

1) Woman who were lactated

2) Women who were pregnant

Data collection tools

It consisted of three tools, as following:

The first tool was self-administrative questionnaire (Questioner: Annex I) which

was developed based on previous studies and some questions in obstetric and

history part , obtained from free questionnaire (Clinic DA, 2010). It consisted of

five parts, which combined multiple-choice questions and yes/no responses was

used:

First part (Q1-Q8): the demographic data included name, age, job,

weight, height, marital status, financial status and place of residency.

Second part (Q9-Q13): of the questionnaire consisted of five questions to

assess medical and surgical history include the presence of certain

diseases, back pain, joint pain and family history osteoporosis.

Page 43 of 129

Third part (Q14-Q27): of the questionnaire involved thirteen questions

about gynecological and obstetric history include pregnancies and

abortion number, menarche age, menopause age, number of breastfeeding

children and duration of breastfeeding and hormone replacement history

include the duration of using it.

Fourth part (Q28-Q36): of the questionnaire consisted of nine questions

to assess nutrition pattern history, which focused on Calcium intake

(milk, yogurt and white cheese intake), soft drink, cola, vitamin D

supplement and smoking.

Fifth part (Q37-Q43): of the questionnaire contained seven questions to

assess the life style of participant as exercises include the duration, type

of exercise and period that spent. Also some questions were told about

the exposure of sun (time and body surface area).

The second tool included blood-sampling test to measure the estrogen

Level and sent to Al-Najah Laboratory and Vitamin level and sent to

Al-Masri Laboratory

The third tool was the DXA device to scan the bone mineral density

(BMD) on two places at lumber site between (L1-L4) and femoral site (hip and

knee ).

Validity and Reliability of the questionnaire

The questionnaire was reviewed to assess the words and effectiveness

that included in it by five instructors based on their experts and their opinions,

some framing of demographic questions was done to be more understandable

for the participants also it was tested by:

Page 44 of 129

Pilot study

It was accomplished after developing of questionnaire on 10% of the

sample aiming to ensure women understanding of the questionnaire, time

needed for fulfilling it and the time for each procedure and as a results about 8-

10 minutes was taken to fulfill the questionnaire by the participants ,some

questions changed to be more accurate and more specific in data analysis and

understood for the women amount of milk intake(Q28) was changed from

(never ,sometimes ,always ) to (Never , (1-3 ) Glass , Week , (4-6) Glass ,Week

and (1 Glass) Every Day( , the procedure (blood sample and DXA device ) for

each women was taken about 30 minutes , and it was included in the sample

size .

Cronbach's (alpha) test

It was done to measure the reliability of the questionnaire by SPSS,

which was (0.607) for 28 items.

Validity and reliability for DXA

History of dual energy X-ray absorptiometry (DXA)

The first technique of BMD measurement was introduced in 1963, as a

single photon absorptiometry (SPA) of the forearm. The limitation of SPA is

make a check for the peripheral skeletal sites only, after that the dual photon

absorptiometry (DPA) was developed 1987. DXA become a gold standard for

BMD measurement at that year because of its high image quality, accuracy and

fast scanning times. According to a 1997 National Osteoporosis Foundation

(NOF) survey, 89% of bone density tests performed in the United States in one

year used DXA. There are three commercial manufacturers of DXA

instruments: Hologic, Lunar, and Norland. The fundamental principle behind

DXA measurement is the use of transmission X-ray through the body by two

Page 45 of 129

different photon energy levels, which are absorbed mineral and soft tissue,

(Zack, 2002).

The Reliability and validity of bone mineral density (BMD) measurement

were examined by QDR-4500A dual energy X-ray absorptiometry (DXA,

Hologic Inc., Bedford, MA) at Virginia Tech on a group of young-adult males

and females. Scanting of the lumbar spine total forearm, total proximal femur

twice, without significant differences between repeated measures. (Zack, 2002),

the use of DXA at hip and lumbar spine is recommended by the WHO in many

studies that referred to the organization, (WHO, 2004).

DXA scanners the lumbar vertebrae and the hip throw an x-ray beam that

measure the shadow cast by the bones. The result is expressed as a number of

grams per square centimeter. DXA scans are two-dimensional, like a plain X-

ray.

The world health association (WHO) classifies T scores in the DXA results as

follows:

* Above -1 SD is normal

* Between -1 and -2.5 SD is defined as decreased bone mineral density

osteopenia

* Below -2.5 SD is defined as osteoporosis

(El Maghraoui, 2012)

BMD test in little hand association

The DEXA in LHS was bring form USA in 2013 , this device model was

Discovery QSR series; operator manual is used to measure the BMD which

synthesized at Hologic for Osteoporosis Assessment in USA.

The Hologic whole body DXA references database software used on

hologic QDR bone densitometers measure the regional and whole body bone

Page 46 of 129

mineral density, the values can be displayed in user defined statically formats

and trends with color image mapping and compared to reference populations at

the sole discretion of the criteria of WHO and health care professional.

Software used in the QDR series was developed using ICE 60601-1-4 as

a guide, the classification of the QDR series X-ray bone demonstration under

this specifications in class 1 type B.

Lumbar spine examination, at first the AP lumbar spine selected from

scan type, after that the patient has been set on their back with their head at the

right end of the table. For femoral examination the patient set by place his foot

positioner under his leg and align its center with the table and the patient

midline, after that the entire leg was rotated 25 degree inward and place the

medial edge of the foot against the petitioner.

Quality control (QC) procedure is daily checked by using phantom, when

auto QS passes, the users click “OK” to start scanning patients .If auto QC fails,

the user follow the instructions to resolve problems . Also check on paper and

ink is daily, and before started working on, the user leave it 15 minutes to start

software and get ready for scanning. Daily it can scan for 30 patients.

Vitamin D test validity and reliability

Test ID: 25 OH vitamin D Two bioequivalent forms of vitamin D:

Vitamin D2: obtained from vegetable sources.

Vitamin D3: synthesized from cholesterol through sun exposure.

Vitamin D deficiency is more common than previously believed,

especially among adolescents, women, and the elderly. The total 25-

hydroxyvitamin D (25-OH-VitD) level (the sum of 25-OH-vitamin D2 and 25-

Page 47 of 129

OH-vitamin D3) is the appropriate indicator of vitamin D body stores.(Mayo

Medical, 2013)

Specimen Type

Serum (blood sample)

Reference Values

Total 25-hydroxyvitamin D2 and D3 (25-OH-vit D)

<19 ng/mL (vitamin D deficiency)

20-50 ng/mL (normal levels)

>51ng/mL (toxicity )

(Mayo Foundation for Medical Education and Research. 2013)

Maximum Laboratory Time

5 days

25-OH vitamin D ELISA for the quantitative measurement of 25-OH

vitamin D in human serum

A kit that was used with references 55500 and contain 96 tests, produced

by HUMAN company in German used for the determination of 25-hydroxy

vitamin D2 and D3, it is stored in the dark at -20 C until the procedure done

within 3 days, all the procedure done according to the procedural note that

attached with the kit, every kit contain:

Microtiter strips 12 MTP.

Vitamin D Calibrator CAL0 2 ml, CAL1 1 ml, CAL5 1 ml.

Vitamin D control 1 Control 2 1 ml

Incubation buffer (INC BUF) 20 ml

Vitamin D conjugate solution (CON 100x) 100µl ,

Conjugate buffer 30 ml ,

HRP solution 200µl ,

Page 48 of 129

Washing buffer 10 ml

Substrate 12 ml

Validation of the vitamin D is based on control 1 and control 2 should be

within the range specified in the vial label if it showed high concentration above

the highest calibrator , should be assayed in dilution by CAL 0.

Quality control samples, should be run according to local regulations, the

results should be within the established ranges.

Validity and reliability of estrogen (Estradiol (E2))

Estrogen is a hormone produced by ovaries and involved in development

of female cell maturation, pregnancy and growth. There are two major type of

estrogens Estriol (E1) and estradiol (E2). E1 is usually used to measure the

estrogen level during pregnancy, E2 used to evaluate the estrogen level in non-

pregnant women and in menopause women because of that the E2 test is

estimated in the study .Estradiol have varies amount during the menstrual cycle

and it is decline to a very low level after menopause and there is vary ranges

from lab to lab (WebMD, 2014).

The kit (Elecsys Estradiol 1370 II reagent kit Cat .No.03000079122-100

test) which contain M 6.5 mL, R1 9 mL , R2 9mL , have been assembled into a

ready-for-use unit that cannot be separated .The sample stored at 2-8 C upright

in the kit to ensure complete availability of the micro particles during automatic

mixing prior to use.

For quality control, use ElecsysPreciControl Universal 1 and 2, controls

for the various concentration ranges should be run as single determination at

least once every 24 hours when the test is in use, once per regent kit, and after

every calibration

The analyzer automatically calculates the analytic concentration of each sample.

Page 49 of 129

Conversion factors: pmol/L x 0.273 = pg/mL

pg/mL x 3.67 = pmol/L

Normal Results

Female (not menopausal ): 15 to 350 pg/mL

Female (menopausal ): < 10 pg/mL

(Mayo Foundation for Medical Education and Research, 2015)

Normal value ranges may vary slightly among different laboratories.

Filed work

Data was collected during August 25 to September 7. Study was

conducted in LHS, the participants were the society reviewers and who saw the

posting event in the Facebook (Annex II). The purpose of the study was

explained to the participant, and then woman answered the questionnaire

themselves. For those women who have some difficulty in reading the

questions, the researcher assisted them. And if it was found missing questions,

participants have been asked to refill the questions, but if the missing data was

found this because the researcher was not available in that time. The blood

sample was taken while the participant waiting their turn in the DXA room, then

the tubes were labeling with women name and coding by numbers, after twice

cheeked then sent to the Al-Masri and Al-Najah laboratory.

In the DXA rooms the work done as the following:

1. Provide the required explanation and instruction to the participant about

the procedure.

2. Took the demographic data (age , name ,weight , height , social status ) ,

gynecologic and reproductive data ( number of children , menopause ,

status of period ) medication (corticosteroids ) calcium intake ,smoking

and other questions and enter it to the software of DXA .

Page 50 of 129

3. Prepare the women for the examination (place and positioning )

4. The participant took a hard copy for her result of DXA , and the results of

vitamin d and estrogen , women have been called by LHS to get their

results and the abnormal results were reviewed by obstetric and

orthopedic doctors .

Page 51 of 129

Data Analysis

Coding and data entry was done using Statistical Package for Social

Science (SPSS).The Statistical analysis tests used in the study were:

Frequency distribution and percentage were used for categorized

variables

Chi square test was used to approve the hypothesis and compare variable

and their distribution.

The dependent variable

Table 1 Values of dependent variables

Dependent variable Operational meaning The level of estrogen (E2)

Female (not menopausal ): 15-350 pg/mL Female (menopausal): <10 pg/mL

Vitamin D <19 ng/mL (vitamin D deficiency) 20-50 ng/mL (normal levels) >51ng/mL (toxicity )

BMD (DXA results) Category T-score rangeNormal T-score ≥ −1.0Osteopenia −2.5 < T-score < −1.0Osteoporosis T-score ≤ −2.5

Independent variable

Table 2 Values of independent variables

Independent variable Value

Age This has three options (35-45, 45-55 and 55< years old).

Marital status This has four options (single, married, divorced, and widowed).

Family history of Osteoporosis Positive or negativeAge at Menarche Numeric valueAge at Menopause Numeric valueamount of milk consumption in glass /week Numeric valuePerforming physical Activities/Exercise Yes/no , amount Usage of hormonal tablet yes/no

Page 52 of 129

Ethical Considerations

The study approved from institutional review board (IRB) (Annex III)

from An-Najah National University in Nablus. After that approval, data

collection started after agreement with the LHS, and the consent form (Annex

IV) was provided to the participant within the second paper of the formed

questioner. In addition, data was kept confidential with the researchers and

supervisor after data collection process, and it was kept privacy and security of

participants.

Financial issues:

The fund was obtained from Palestinian Bible Society (Annex V).

Budget

Table 3 Budget

Tool / TestName

Cost for single participant

Number for Participants

Number of participants * cost of single participant

Total

Estrogen test 50-70 NIS 300 300 *60 18,000 NIS

Vitamin D50-70 NIS 150 150*60

DXA 100 NIS 300 300*100 30,000 NISOthers; Copying,Transportation.

50 4 50 * 40 200 NIS

48,200 NIS

Page 53 of 129

Results

Table (1) Distribution of percentage of participant’s regarding to their demographic data

Item No. %

Place of residency

City 251 83.7Camp 9 3.0Village 40 13.3Total 300 100.0

Age(35-44) 100 33.3(45-55) 100 33.3≥ 55 100 33.3Total 300 100.0

Work Status of the employee

Employee 62 20.7House wife 226 75.3Other 12 4.0Total 300 100.0

Monthly Income

≤ 1000 NIS 76 25.3(1000-1999) NIS 99 33.0(2000-2999) NIS 89 29.7More than 3000 NIS 36 12.0Total 300 100.0

Marital statusSingle 42 14.0Married 221 73.7Divorced 6 2.0Widow 31 10.3Total 300 100.0

BMI CAT

< 18 (underweight) 3 1(18-24.9) normal 65 21.7(25-30)over weight 106 35.3> 30 (obesity) 126 42.0Total 300 100.0

Table (1) showed that (83.7%) of participants reported that they live in

city. And (75.3%) of them, are housewife. Regarding to marital status (73.7%)

of them reported that they are married. Moreover there were (33%) of

participants reported that their income was (1000-1999) NIS

Page 54 of 129

Table (2) Distribution of participants according to medical and surgical history

Item No. %

Previous Surgical history

Yes 164 54.7No 136 45.3Total 300 100

History of any disease

Hypertension 85 28.3Diabetes 42 14Thyroid disease 6 2Rheumatoid arthritis 70 23.3Have no Disease 163 54.3

Complain of Back pain

Yes 200 66.7No 98 32.7Total 298 99.3Missing 2 0.7Total 300 100

Complain of joint pain

Walking on flat land 56 26.3Raise a stairs 173 57.7Raise a high place 99 33Kneeling when praying 130 43Have no pain 73 24.3

Family history of Osteoporosis

Yes 83 27.7No 211 70.3Missing 6 2Total 300 100

Table (2) showed that (54.7%) of participants reported that they have

previous surgical history, (28.3%) of them have Hypertension, while (54.3%) of

them they have no disease. According to joint pain (57.7%) of participants

reported that they have a joint pain during raise a stairs and (43%) of them

reported that they have a joint pain during kneeling when praying. In addition

there was (70.3%) of them they have no family history of osteoporosis.

Table (3.1) Distribution of participants according to their obstetrics history

Page 55 of 129

Item No. %Number of Gravida No Pregnancies 53 17.7

≤ 2 24 8.0(3-5) 119 39.6 ≥ 5 104 34.7Total 300 100.0

Number of Parity Not Giving Birth 55 18.3≤ 2 23 7.73-5 134 44.7>5 88 29.3Total 300 100.0

number of Abortion No Abortion 190 63.3≤ 2 99 33.03-5 7 2.3>5 3 1.0Total 299 99.7Missing 1 .3Total 300 100.0

Length of Period <18 99 33.0(18-24) 102 34.0(24-28) 80 26.7>28 15 5.0Missing 4 1.3Total 300 100.0

Status of period Regular 104 34.7Irregular 46 15.3Menopause 150 50.0Total 300 100.0

Menopause period / since

<1 Year 23 7.7(1-3) Year 30 10>3 Year 103 34.3It’s Not Menopause 142 47.3Missing 2 .7Total 300 100.0

Table (3.1) showed that (39.6%) of participants reported that they have

(3-5) pregnancies. According to number of parity (44.7%) of participants they

have (3-5) children. In addition (34%) of participants reported that the length of

their menstrual period was (18-24) day. According to status of period, (34.7%)

of them reported that they have regular period, also (34.3%) of participants

reported that they have been menopause more than 3 years ago.

Table (3.2) Distribution of participants according to their breast feeding history

Item No. %

Page 56 of 129

History of Breast feeding

Yes 228 76.0No 16 5.3Have No Children 56 18.7Total 300 100.0

No. of Breast Fed Children

1-3 65 21.7(4-6) 127 42.3>6 Months 37 12.3Have No Children 56 18.7Did Not Breast Fed 14 4.7Total 299 99.7Missing 1 .3Total 300 100.0

Period of Breast Feeding

<6 Months 29 9.76 Months To 1 Year 86 28.7>1 Year 114 38.0Have No Children 55 18.3Did Not Breast Fed 14 4.7Total 298 99.3Missing 2 .7Total 300 100.0

Usage of hormonal tablet

Yes 88 29.3No 212 70.7Total 300 100.0

Reason of hormonal Usage

Contraception 78 26Hormone Replacement 11 3.7Did Not Use 211 70.3Total 300 100.0

Period of hormonal

<1 Year 31 10.3(1-3) 29 9.7>3 Year 25 8.3Did Not Use 211 70.3Total 296 98.7Missing 4 1.3Total 300 100.0

Table (3.2) showed that (76%) of participants reported that they have a

history of breast feeding, (42.3%) of them reported that a number of breast fed

children was between (4-6) children. According to period of breast feeding,

(38%) of them reported that they fed their children for more than 1 year. In

addition (70.7%) of participants reported that they did not use hormonal tablet.

While (26%) of them reported that they use hormonal tablet for contraception.

Table (4) Distribution of percentage of participants according to their life style and nutrition

Item No. %

Page 57 of 129

Amount of milk consumption in glass /week

Never 99 33.0(1-3 )Glass / Week 126 42.0(4-6) Glass /Week 10 3.3(1 Glass) Every Day 65 21.7Total 300 100.0

Amount Of Cheese Consumption In piece /week

Never 7 2.3(1-3) Piece /Week 121 40.3(4-6) Piece / Week 52 17.3(1 Piece Every Day) 120 40.0Total 300 100.0

Amount of yogurt consumption in glass /week

Never 15 5.0(1-3 )Glass / Week 155 51.7(4-6) Glass /Week 30 10.0(1 Glass )Every Day 100 33.3Total 300 100.0

Amount of soft drinks consumption in glass / week

Never 78 26.0(1-3 )Glass / Week 158 52.7( 4-6 )Glass / Week 23 7.7(1 Glass Every Day 39 13.0Total 298 99.3Missing 2 .7Total 300 100.0

Taking calcium supplements per day

Always 30 10.0Sometimes 97 32.3Never 173 57.7Total 300 100.0

Taking vitamin D per day

Always 26 8.7Sometimes 83 27.7Never 188 62.7Total 297 99.0Missing 3 1.0

Total 300 100

SmokingYes 97 32.3No 203 67.7Total 300 100.0

Table (4) showed that (42%) of participants reported that they used to

consume (1-3) glasses of milk per week. In addition (2.3%) of them reported

that they never ate cheese. Also it showed (51.7%) of them that they consumed

(1-3) Glass of yogurt /week. Regarding to the amount of soft drinks

consumption, (52.7%) of them consumed (1-3) glass /week. Also it showed

(57.7%) of the participants reported that they have never taken calcium

supplement, and (8.7%) of them reported that they always take vitamin D every

Page 58 of 129

day. Regarding to the smoking status, (32.3%) of participants reported that they

smoke.

Table (5) Distribution of percentage of participants according to their physical activity

Item No. %

Performing physical Activities/Exercise

Yes 83 27.7No 187 62.3Sometimes 30 10.0Total 300 100.0

Type of ExerciseWalking 102 34Running 16 3.6Another Exercises 10 5.3Don’t Do Any Exercise 188 62.7Total 300 100.0

Duration of exercise in minuets /day

<30 Minute 49 16.3(30 Minute) 36 12.0>30 Minute 27 9.0Don’t Do Any Exercise 188 62.7Total 300 100.0

Days number of exercise performing /week

1-3 Days / Week 56 18.7( 4-6) Day / Week 15 5.0Daily 28 9.3Don’t Do Any Exercise 188 62.7Total 287 95.7Missing 13 4.3

Total 300 100

Table (5) showed that (27.7%) of the participants reported that they

perform physical activity, and (34%) of them perform walking exercise.

According to duration of exercise in minute per day, (9%) of the participants

reported that they spent more than 30 minutes doing Exercises and (5%) of

them were performing exercises from (4-6) day per week.

Table (6) Distribution of percentage of participants according to sun exposure

Page 59 of 129

Item No. %

Sun exposureYes 227 75.7No Exposure 73 24.3Total 300 100.0

Body parts to sun Exposure

Hands 5 1.6Legs 7 2.4Face 18 6.0Hands and Face 112 37.3Hands, Legs and Face 21 6.9All Body 44 14.7Hands, Legs 13 4.3Back ,Hand, Legs 4 1.3Don’t Exposed 72 24.0Missing 4 1.2Total 300 100.0

Duration of Sun Exposure in mint

<30 Min 129 43.0(30 Min) 50 16.7>30 Min 49 16.3Don’t Exposed 72 24.0Total 300 100.0

Table (6) showed that (24.4%) of participants reported that they haven’t

exposed to the sun. While (37.3%) of them reported that the body parts which

were exposed to sun were hands and face, and (16.3%) of them were spent more

than 30 minutes to exposure of sun.

Table (7) Distribution of percentage of participants BMD of femoral and lumber results

Item No. %

Page 60 of 129

BMD of femoral Normal 176 58.7Osteopenia 108 36.0Osteoporosis 16 5.3Total 300 100.0

BMD of lumberNormal 156 52.0Osteopenia 107 35.7Osteoporosis 37 12.3Total 300 100.0

Vit D serum

<19 37 23.120-50 122 76.3>51 1 .6Total 160 100.0

Estrogen serum(15-350) 111 37.0(<15) 39 13.0Menopause.(>10) 98 32.7Menopause.(<10) 52 17.3

Total 300 100.0

Estrogen serum at age 35-44

15-350 75 75.0Less than 15 20 20.0Menopause.(>10) 4 4.0Menopause.(<10) 1 1.0Total 100 100.0

Estrogen serum at age 45-55

15-350 35 35.0Less than 15 17 17.0Menopause.(>10) 34 34.0Menopause.(<10) 14 14.0Total 100 100.0

Estrogen serum at age >55

15-350 2 2.0Less than 15 1 1.0Menopause.(>10) 60 60.0Menopause.(<10) 37 37.0Total 100 100.0

Estrogen serum for women have regularPeriod

15-350 76 76.0Less than 15 24 24.0

Total 100 100.0

Estrogen serum for women have irregular period

15-350 72 72.0Less than 15 28 28.0Total 100 100.0

Estrogen serum for women who were menopause

Menopause.(>10) 65 65.0Menopause.(<10) 35 35.0Total 100 100.0

Table (7) showed that (5.3%) of participants have femoral osteoporosis,

(12.3%) of them have lumber osteoporosis. Also it showed that there were

(76.3%) of them have normal results of Vit D (20-50). Moreover (37%) non–

Page 61 of 129

menopausal participant their results of estrogen were (15-350) and(17.3%) of

menopausal women their results were less than (10).

Estrogen serum level according to age

75%

20%

4%1%

Estrogen level at age 35-44

(15-350)

(less than 15)

35%

17%

34%

14%

Estrogen level at age 45-55

(15-350)(less than 15)menopause.(more than 10 )menopause.(less than 10)

2% 1%

60%

37%

Estrogen level at age >55

(15-350)

(less than 15)

menopause.(more than 10 )

menopause.(less than 10)

Page 62 of 129

Estrogen serum level according status of period

76%

24%

women have reguler period(15-350) (less than 15)

72%

28%

women have ir-regular period

(15-350) (less than 15)

65%

35%

women were menopause

(more than 10 )(less than 10)

Table 6Distribution of participants’ percentage according to their age and BMD

Page 63 of 129

Age

BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal osteopeni

aosteoporosi

sN % N % N % N % N % N %

(35-44) 74 74.0 25 25.0 1 1.0 75 26.

0 24 8.0 1 0.3

(45-55) 63 63.0 34 34.0 3 3.0 49 16.

3 40 13.3 11 3.7

> 55 39 39.0 49 49.0 12 12.0 32 10.

7 43 14.3 25 8.3

Total 176

58.7 108 36.0 16 5.0 15

652.0 107 35.7 37 12.3

Chi- Square 31.96 47.4

P value .000 0.00

Pearson Correlation

0.315 .392

Table (8) showed that (1%) of participants who were at age group (35-45)

year have a femoral osteoporosis and (0.3%) of them have lumber osteoporosis.

While (12%) of participants who were more than 55 year old have femoral

osteoporosis and (12.3%) of them have lumber osteoporosis. The table also

showed that there was positive relationship between age and BMD, as P value

(0.000) < (0.05).

Page 64 of 129

Figure 1 Correlation between age and femoral BMD

Figure 2 Correlation between age and lumber BMD

Table (9) Distribution of participants according to BMI and BMD

BMI

BMD of femoral BMD of lumberNormal Osteopenia Osteoporosis Normal Osteopenia OsteoporosisN % N % N % N % N % N %

<18(Under Wt) 1 0.3 2 0.7 0 0 3 1 0 0 0 0

(18-24.9)Normal 26 8.7 31 10.3 8 2.7 31 10.

3 23 7.7 11 3.7

(25-30)Over Wt 61 20.3 41 13.7 4 1.3 54 18 38 12.7 14 4.7

>30(Obesity) 88 29.3 34 11.3 4 1.3 68 22.

7 46 15.3 12 4

Total 176 58.7 108 36 16 5.3 156 52 107 35.7 37 12.3

Chi-Square 20.8 5.1

P value .02 0.52

Pearson -.242 -.049

Page 65 of 129

Correlation

Table (9) showed that nobody (0%) of participants who were under

weight (BMI less than 18) have an osteoporosis .While (1.3%) of them who

were obese have femoral osteoporosis and (4%) of them have lumber

osteoporosis. it was showed that there was negative relationship between BMI

and BMD, as P value (0.02) < (0.05).

Figure 3Correlation between BMI and lumber BMD

Table (10) Distribution of participants percentage according to calcium consumption and BMD

Calcium

BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporosi

sN % N % N % N % N % N %

low 7 2.3 6 2.0 1 0.3 8 2.7 5 1.7 1 0.3

Moderate

5418.0

31 10.3 6 2.0 5117.0

31 10.3 9 3.0

High 105

38.3

71 23.7 9 3.0 9732.3

71 23.7 27 9.0

Total176

58.7

108 36.0 16 5.3156

52.0

107 35.7 37 12.3

Chi-square 1.02 1.75

P value 0.907 .78

Page 66 of 129

Table (10) showed that (2.3%) of participants who consumed low amount

of dietary calcium, have normal result of femoral BMD, and (1.7%) of them

have normal result of lumber BMD. While (38.3%) of them who consume high

amount of dietary calcium have normal result of femoral BMD and (52%) of

them have normal result of lumber BMD. Also it was showed that there was no

relationship between calcium consumption and BMD, as P value (0.907) >

(0.05).

Table (11) Distribution of participant’s percentage according to amount of milk consumption /Week and BMD

Amount of milk consumption in glass /week

BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporosi

s

N % N % N % N % N % N %

Never 58 19.3 34 11.

3 7 2.3 58 19.3 31 10.3 10 3.3

(1_3)glass /week 78 26.

0 42 14.0 6 2.0 79 23.

0 45 15.0 12 4.0

(4_6) glass/week 5 1.7 5 1.7 0 0.0 1 0.3 4 1.3 5 1.7

1 glass/day 35 11.7 27 9.0 3 1.0 28 9.3 27 9.0 10 3.3

Page 67 of 129

Total 176

58.7 108 36.

0 16 5.3 156

52.0 107 35.7 37 12.3

Chi-Square 3.26 19.806

P value .77 .003

Pearson Correlation No test because P value more than 0.05 .140

Table (11) showed that (2.3%) of participants who never drank milk have

femoral osteoporosis and (3.3%) of them have lumber osteoporosis, while (1%) of

participants who drank one glass daily have femoral osteoporosis and (3.3%) of

them have lumber osteoporosis. It was also showed that there was positive

relationship between milk consumption and BMD, as P value showed (0.003) <

(0.05).

Page 68 of 129

Figure 4Distribution of Participant’s Percentage according to amount of Milk Consumption /Week and BMD

Table (12) Distributionof participants percentage according to dose of sun exposure/min and BMD

Page 69 of 129

Dose of Sun Exposure

BMD of Femoral BMD of Lumber

Normal Osteopenia Osteoporosis Normal Osteopeni

aOsteoporosi

sN % N % N % N % N % N %

Don’t Expose 76 25.3 45 15.

0 8 2.7 36

12.0 28 9.4 9 3.0

One Part (Minimal Exposure)

27 9.0 21 7.0 2 0.7 15 5.0 10 3.3 6 2.0

Two Parts or More (recommended)

32 10.7 16 5.3 1 0.3 8

327.8 51 17.

1 17 5.7

All Body 41 13.7 26 8.7 5 1.7 2

1 7.0 18 6.0 5 1.7

Total 176

58.7

108

36.0 16 5.3

155

51.8

107

35.8 37 12.4

Chi-Square 7.53 2.7

P value .27 .84

Table (12) showed that (2.7%) of participants who did not exposed to sun

have femoral osteoporosis and (3%) of them have lumber osteoporosis. While

(1.7%) of participants who exposed their body to sun have femoral osteoporosis

also (1.7%) of them have lumber osteoporosis.it was also showed that there was

no relationship between dose of sun exposure and BMD, asP value (.27),(.84) >

(0.05).

Table (13) Distribution of participant’s percentage according to duration of sun exposure and BMD

BMD of Femoral BMD Of Lumber

Page 70 of 129

Duration Of Sun Exposure

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

<30 Min 76 25.3 45 15.0 8 2.7 69 23.0 44 14.7 16 5.3

30 Min 27 9.0 21 7.0 2 0,7 23 7.7 18 6.0 9 3.0

>30 Min 32 10.7 16 5.3 1 0.3 27 9.0 18 6.0 4 1.3

Don't Expose

41 13.7 26 8.7 5 1.7 37 12.3 27 9.0 8 2.7

Total 176 58.7 108 36.0 16 5.3 156 50.0 107 35.7 37 12.3

Chi-Square 2.98 2.7

P value .81 .83

Table (13) showed that (2.7%) of participants who exposed to sun less

than 30 min have a femoral osteoporosis and (5.3%) of them have lumber

osteoporosis, while (1.7 %) of participants who don’t expose to sun have

femoral osteoporosis and (2.7%) of them have lumber osteoporosis, also it was

showed that it was no relationship between duration of sun exposure and BMD,

as P Value (0.81), (0.83) > (0.05) .

Table 7Distribution of participant’s percentage according to number of parity and BMD

Page 71 of 129

Number Of Parity

BMD of Femoral BMD of Lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

Nothing 27 9.0 23 7.7 5 1.7 27 9.0 20 6.7 8 2.7

≤ 2 15 5.0 8 2.7 0 0.0 13 4.3 9 3.0 1 0.3

(3-5) 87 29.0 39 13.0 8 2.7 81 27.0 36 12.0 17 5.7

>5 47 15.7 38 12.7 3 1.0 35 11.7 42 14.0 11 3.7

Total 176 58.7 108 36.0 16 5.3 156 52.0 107 35.7 37 12.3

Chi-Square 9.290 12.556

P value .158 .051

Table (14) showed that (29%) of participants who reported that number

of parity for them is (3-5) children, have normal result of femoral BMD and

(27%) of them have normal result of lumber BMD. However (9%) of

Participants who reported that they have no children, have normal result of

femoral and lumber BMD. It was also showed there was no relationship

between number of parity and BMD, as P value (0.158), (0.051) > (0.05).

Table (15) Distribution of participants percentage according to amount of cheese consumption per week and BMD

Page 72 of 129

Amount of Cheese consumption

BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporosi

sN % N % N % N % N % N %

Never 4 1.3 3 1.0 0 0.0 3 1.0 4 1.3 0 0.0

(1-3) /Week 77 25.

7 39 13.0 5 1.7 74 24.7 34 11.3 13 4.3

(4 -6)/Week 27 9.0 21 7.0 4 1.3 23 7.7 22 7.3 7 2.3

(1 Piece Every Day) 68 22.

7 45 15.0 7 2.3 56 18.7 47 15.7 17 5.7

Total 176

58.7 108 36.0 16 5.3 15

652.0 107 35.7 37 12.3

Chi-Square

3.218 8.719

P value .781 .190

Table (15) showed that (25.7%) of participants who consumed (1-3) piece

per week have normal results of femoral BMD and (24.7%) of them have

normal results of lumber BMD. While (1.3%) of participants did not consume

cheese have normal result of femoral BMD and (1%) of them have normal

result of femoral BMD .It was also showed that was no relationship between

amount of cheese consumption and BMD, as P value (0.781), (0.190) > (0.05).

Page 73 of 129

Table (16) Distribution of participants percentage according to amount of soft drinks per week and BMD

Amount Of Soft Drinks

BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporosi

sN % N % N % N % N % N %

Never 48 16.1 26 8.7 4 1.3 38 12.

8 25 8.4 15 5

(1-3) /Week 98 32.

9 48 16.1 12 4.0 87 29.

2 53 17.8 18 6

(4 -6)/Week 13 4.4 10 3.4 0 0.0 11 3.7 10 3.4 2 .7

(1 Glass Every Day) 16 5.4 23 7.7 0 0.0 19 6.4 18 6 2 .7

Total 175

58.7 107 35.

9 16 5.4 155 52.0 106 35.

6 37 12.4

Chi-Square 14.9 7.666

P value .021 .264

Pearson Correlation .068 **

Table (16) showed that (1.3%) of participants did not drink soft drink have

femoral osteoporosis and (5 %) of them have lumber osteoporosis. In addition

(7.7%) of participants drank one glass daily have femoral osteopenia and (6%) of

them have lumber osteopenia. Also it showed that there was positive relationship

between of amount of soft drink and BMD, as P value (0.021) < (0.05)

Figure 5Correlation between amount of soft drinks consumption and BMD of femoral

Page 74 of 129

Table (17) Distribution of participant's percentage according to amount of yogurt intake per week and BMD

Amount Of Yogurt

BMD of lumber BMD of femoral

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

Never 8 2.7 5 1.7 2 .7 8 2.7 6 2 1 .3

(1-3) /Week 86 28.7 52 17.3 17 5.7 96 32 52 17.3 7 2.3

(4 -6)/Week 16 5.3 11 3.7 3 1 18 6 11 3.7 1 .3

(1 Glass Every Day)

46 15.3 39 13 15 5 54 18 39 13 7 2.3

Total 156 52 107 35.7 37 12.3 176 58.7 108 36 16 5.3

Chi-Square 2.5 2.3

P value .86 .89

Table (17) showed that (28.7%) of participants who consumed (1-3) glass

per week have normal results of lumber BMD and (32%) of them have normal

results of femoral BMD. While (2.7%) of participants who don't consume

yogurt have normal result of femoral and lumber BMD. Also it was showed that

there was no relationship between amount of yogurt and BMD, as P value

(0.86),(0.89) > (0.05).

Page 75 of 129

Table 8Distribution of participants percentage according to duration of exercise in minute and BMD

Duration of exercise in minute

BMD of Femoral BMD of Lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

<30 M 13 11 14 4.7 2 .7 37 12.3 9 3.0 3 1.0

30 Min 25 8.3 10 3.3 1 .3 19 6.3 13 4.3 4 1.3

>30 M 18 6 7 2.3 2 .7 13 4.3 13 4.3 1 0.3

Don't Do Exercise 100 33.33 77 25.7 11 3.7 87 29.0 72 24.0 29 9.7

Total 167 58.7 108 36 16 5.3 156 52.0 107 35.7 37 12.3

Chi-Square 6.9 16.7

P value 0.32 0.01

Pearson Correlation ** 0.19

Table (18) showed that (3.7%) of participants who did not do exercise

have femoral osteoporosis and (9.7%) of them have lumber osteoporosis. In

addition, (14%) of participants who performed exercise less than 30 minute

have normal result of femoral BMD and (12.3%) of them have normal result of

lumber BMD. It was also showed that there was positive relationship between

duration of exercise and BMD, as P value (0.01) < (0.05).

Page 76 of 129

Figure 6 Duration of exercise in minutes / day

Page 77 of 129

Table (19) Distribution of participants according to number of smoked cigarettes and BMD

Number Of Smoked Cigarettes

BMD Of Femoral BMD Of Lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %(1-10) 9 3.0 9 3.0 0 0.0 9 3.0 8 2.7 1 0.0

(11-20) 1 0.3 2 0.7 2 0.7 1 0.3 2 0.7 2 0.7

> 20 3 1.0 2 0.7 0 0.0 4 1.3 1 0.3 0 0.0

Don’t Smoke 163 54.3 95 31.7 14 4.7 142 47.3 96 32.0 34 11.3

Total 176 58.7 108 36.0 16 5.3 156 52.0 107 35.7 37 12.3

Chi-Square 15.202 6.921

P value .019 .328

Pearson correlation 0.030 **

Table (19) showed that (54.3%) of participants who don't smoke, has

normal result of femoral BMD and (47.3%) of them have normal result of

lumber BMD. While (3%) of participants who smoke one to ten cigarettes have

normal result of femoral and lumber BMD. Also it was showed that there was

positive relationship between number of smoked cigarettes and BMD, as P

value (.019) < (0.05).

Page 78 of 129

Figure 7 Number of smoked cigarettes/day

Page 79 of 129

Table (20) Distribution of participants percentage according to status of menstrual period

Status of period

BMD of femoral BMD of lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

Regular 77 25.7 26 8.7 1 .3 74 24 30 10 0 0

Irregular 35 11.7 11 3.7 0 0.0 30 10 13 4.3 3 1

Menopause 64 21.3 71 23.7 15 5 52 21.3 64 11.3 34 11.3

Total 176 58.7 108 36 16 5.3 156 52 107 35.7 37 12.3

Chi-square 36.13 48.74

P value 0.000 0.000

Pearson correlation .318 .391

Table (20) showed that (25.7%) of participants who have regular

menstrual period, have normal results of femoral BMD and (24%) of them have

normal results of lumber BMD. While (21.3%) of participants who were

menopause have normal result of femoral and lumber BMD. Also it was

showed that there was positive relationship between status of period and BMD,

P value (0.000) < (0.05).

Figure 8Status of period and femoral BMD

Page 80 of 129

Figure 9 Status of period and lumber BMD

Page 81 of 129

Table (21) Distribution of participants percentage according to menopause period and BMD

Menopause period/since

BMD of femoral BMD of lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporos

isN % N % N % N % N % N %

<year 13 4.4 9 3 1 .3 10 3.4 10 3.4 3 1

(1-3) 16 5.4 13 4.4 1 .3 14 4.7 9 3 7 2.3

>3 year 39 13.1 51 17.

1 13 4.4 31 10.4 46 15.4 26 8.7

It's not menopause 106 35.

6 35 11.7 1 0.3 10

033.6 41 13.8 1 0.3

Total 174 58.4 108 36.

2 16 5.4 155 52 106 35.6 37 12.4

Chi-square 40.86 56.3

P value 0.00 0.00

Pearson correlation .362 .420

Table (21) showed that (0.3%) of participants who were less than one

year menopauses have femoral osteoporosis and (1%) of them have lumber

osteoporosis. While (4.4%) of participants who were more 3 year menopause

have femoral osteoporosis and (8.7%) of them have lumber osteoporosis. Also it

was showed that there was positive relationship between menopause period and

BMD, as P value (0.00) < (0.05).

Page 82 of 129

Figure 10Correlation between menopause period and femoral BMD

Figure 11 Correlation between menopause period and BMD

Page 83 of 129

Table (22)Distribution of participants according to number of breast fed children and BMD

No.of Breast Fed Children

BMD of Femoral BMD of Lumber

Normal Osteopenia Osteoporosis Normal Osteopeni

a Osteoporosis

N % N % N % N % N % N %

1-3 36 12 24 8 5 1.7 34 11.4 21 7 10 3.3

4-6 90 30.1 34 11.4 3 1 75 25.1 41 13.7 11 3.7

More Than 6 12 4 22 7.4 3 1 9 3 22 7.4 6 2

Have No Children 28 9.4 23 7.7 5 1.7 29 9.7 19 6.4 8 2.7

Didn't Breast Fed 9 3 5 1.7 0 0 8 2.7 4 1.3 2 .7

Chi-square 22.9 16.04

P value 0.003 0.042

Pearson correlation 0.078 0.045

Table (22) showed that (4%) of participants who did breastfed to more

than 6 children have normal result of femoral BMD and (3%) of them has

normal result of lumber BMD. While (12%) of participants who did breast fed

to (1-3) children have normal result of femoral BMD and (11.4%) of them have

normal result of lumber BMD. Also it was showed that there was positive

relationship between numbers of breast fed children and BMD, P value (.003),

(0.042) < (0.05).

Page 84 of 129

Figure 12No. of breast fed children and BMD of femoral

Figure 13No. of breast fed children and BMD of lumber

Page 85 of 129

Table (23) Distribution of participants according to family history of osteoporosis and BMD

Family history of osteoporosis

BMD of femoral BMD of lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

Yes 47 16.0 29 9.9 7 2.4 36 12.2 37 12.6 10 3.4

No 125 42.5 77 26.2 9 3.1 117 39.8 68 23.1 26 8.8

Total 172 58.5 106 36.1 16 5.4 153 52.0 105 35.7 36 12.2

Chi-Square 2.011 4.217

P value .366 .121

Table (23) showed that (16%) of participants who have a family history

of osteoporosis, has normal result of femoral BMD and (12.2%) of them have

normal result of lumber BMD. While (42.5%) of participants who have not

family history of osteoporosis, have normal result of femoral BMD and (39.8%)

of them have normal result of lumber BMD. Also it was showed that there is no

relationship between family history of osteoporosis and BMD, as P value (.366),

(.121) > (0.05).

Page 86 of 129

Table 9Distribution of participants according to usage of hormonal tablet and BMD

Using of hormonal tablet

BMD of femoral BMD of lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %

Yes 52 17.3 34 11.3 2 0.7 54 18.0 27 9.0 7 2.3

No 124 41.3 74 24.7 14 4.7 102 34.0 80 26.7 30 10.0

Total 176 58.7 108 36.0 16 5.3 156 52.0 107 35.7 37 12.3

Chi-Square 2.431 4.903

P value .296 .086

Table (24) showed that (0.7%) of participants who used hormonal tablet

have femoral osteoporosis and (2.3%) of them have lumber osteoporosis. While

(4.7%) of participants who did not use hormonal tablet, have femoral

osteoporosis and (10%) of them have normal lumber osteoporosis. Also it was

showed that it was no relationship between using of hormonal tablet and BMD,

as P value (.296), (.086) > (0.05).

Page 87 of 129

Table (25) Distribution of participant’s percentage according to Vit D and BMD

Vit D Range BMD of Femoral BMD of Lumber

Normal Osteopenia Osteoporosis Normal Osteopenia Osteoporosis

N % N % N % N % N % N %<19 (Deficiency) 22 13.8 10 6.3 0 0 18 11.4 11 7 3 1.9

20-50( Normal Level )

82 51.6 35 22 9 5.7 61 38.6 46 29.1 18 11.4

>50 (Increased ) 1 0.6 0 0 0 0 1 0.6 0 0 0 0

Total 105 66 45 28.3 9 5.7 80 50.6 57 36.1 21 13.3

Chi-Square 2.978 1.786

P Value .561 .775

Table (25) showed that (51.6%) of participant who have normal level

ofVit D (20-50), have normal result of femoral BMD, while (38.6%) of them

have normal result of lumber BMD. (13.8%) of participants who have

deficiency in Vit D (less than 19), they have normal result of femoral BMD and

(11.4%) of them have normal result of lumber BMD. Also it was showed that

there was no relationship between Vit D and BMD, as P value (2.978), (1.786)

> (0.05).

Page 88 of 129

Table 10Distribution of participants according estrogen level among different groups and BMD

Estrogen level BMD of Femoral BMD of Lumber

Normal Osteopenia

Osteoporosis Normal Osteopeni

aOsteoporosi

s

N % N % N % N % N % N %

(15-350) 83 27.7 27 9 1 0.3 75 2

5 34 11.3 2 0.7

(<15) 31 10.3 8 2.7 0 0 30 1

0 8 2.7 1 0.3

Menopause.(>10) 45 15 43 14.

3 10 3.3 36 12 41 13.

7 21 7

Menopause.(<10) 17 5.7 30 10 5 1.7 15 5 24 8 13 4.3

Total 176

58.7

108 36 16 5.3 15

652

107

35.7 37 12.3

Chi-Square 44.090 51.872

P value 0.000 0.000

Pearson Correlation -.133 -.122

Table (26) showed that (0.3%) of participants who were pre-menopause

and have normal level of estrogen hormone (15-350), have femoral

osteoporosis, while (0.7) of them has lumber osteoporosis. There was (3.3%) of

participants who were post-menopause and who have abnormal result of

estrogen hormone, have femoral osteoporosis, while (7%) of them have lumber

osteoporosis. Also it was showed that there was negative relationship between

estrogen level and BMD, as P value (0.000) < (0.05).

Page 89 of 129

Figure 14 Correlation between estrogen and femoral BMD

Figure 15correlation between estrogen and lumber BMD

Page 90 of 129

Discussion

The results of the study in (Table1) showed that more than two quarter

(73.7%) of the participants were married, also two third of them (75.3%) were

housewife and a third (33%) of them their income was (1000-1999) NIS, this

results was reflect with Palestinian Central Bureau of Statistics (PCBS) , which

found that (56%) of women in Nablus in 2010 were married and the percentages

are continually increases , while (36.1%) of Palestinian women were single ,

and the average of income in Palestinian family in 2011 was 1058.4 ,

(PCBS,2011). Also the table showed that less than half of participants (42%)

were obese (more than 30 kg/m2).

According to medical and surgical history, the study finding in (Table 2)

showed that one third of them (27.7%) have history of family osteoporosis and

less than of one third of them (28.3%) were have Hypertension which was

reflect with PCBS in 2010 , which found that (16%) of women were have

Hypertension.

Study findings in (Table 3.1) showed that nearly more than one-third of

participants (44.7%) have( 3-5) children and this reflect with PCBS in 2009

which found that the average of fertility in Palestine was 4.4 and this mean that

the Palestinian women have high parity , (PCBS,2009) . According to status of

period of participants, the results showed that half (50%) of them were

menopause and only (15.3%) were with irregular period. In addition, (25.7%) of

them with regular menstrual period, have normal result of femoral BMD.

According to breast feeding history of participants, the study finding in

(Table 3.2) that three quarter of the participants (76%) have a history of breast-

feeding which reflect with PCBS in 2011 that found (98.5%) of women were

fed their children and less than half of them (42.3%) have breast fed (4-6) child

of their children. Also (38%) of them have breast fed their children for more

Page 91 of 129

than one year. Also the results showed that (70.7%) of participants didn’t used

hormonal tablet, only (8.3%) of them used hormonal tablet for more than 3

years which was reflect with PCBS in 2011 that found that (26.3%) of women

were used tablet hormone .

Table (4) indicated that almost of the participants, more than third of

them (42%) were consumed 1-3 glass of milk /week, while it showed that just

(1%) of them who drank one glass daily have femoral osteoporosis. Also less

than half of them (40%) were consumed (1-3) piece of cheese per week. And

half of them (51.7%) were consumed (1-3) glasses of yogurt per week. In

addition more than half (52.7%) of them consumed (1-3) glass of soft drink per

week. Regarding to smoking status, (32.3%) reported that they smoked which

was not reflect with PCBS in 2010 that found (2.4%) of women were smoked.

The study results in Table (5) showed that more than two third (62.3%) of

the participants did not perform physical activity which was reflect with PCBS

in 2011 who found that (33.1%) of women perform physical activity and only

(9%) of them were exercise for more than thirty minutes.

The study results in Table (6) Indicated that more than two quarter

(75.7%) of participant have exposed to sun, more than one third (37.3%) of

them they exposed their hands and face to sun , and (16.3%) of them were spent

more than 30 minutes to exposure of sun.

The study results in Table (7) showed that just (5.3%) of participants

have femoral osteoporosis and this reflect with PCBS in 2012 which found that

the incidence of osteoporosis on women (0.5%). Also the table showed that

more than two quarter (76.3%) of participants have normal results of Vit D (20-

50) Moreover, more than one third (37%) of pre –menopausal participants,

Page 92 of 129

their results of estrogen were (15-350) and (17.3%) of post-menopausal

participants, their results were less than (10 pg /mL).

According to the relationship between participants age and their BMD,

table (8) showed that only (1%) of participants who were at age group (35-45)

year have a femoral osteoporosis ,while (12%) of the them who were more than

55 years old have femoral osteoporosis. Also it was showed that there was a

positive relationship between ageing and decreasing BMD results (p.0.000),

this was consistent with (Wadolowska et al, 2013) who found that women in

Poland ,who were older than 49 years was with low BMD , while women who

were younger than 49 years their results showed regular and normal BMD.Also

the results were similar with (Stevenson, Lees, Devenport, Cust and Ganger,

1989), (Kröger ,Tuppurainen , Honkanen, Alhava and Saarikoski, 1994) and

( Kleerekoper, Brienza, Schultz & Johnson , 1991 ) they consider that

menopause status and age are risk factors that affect the BMD results as

postmenopausal women had a clearly effect on decreasing the BMD results ,

also(Agrawala &Vermab , 2013) found that there was a negative correlation

between age of the women and BMD.

The relationship between BMI of participants and their BMD by table (9)

showed that nobody (0%) of them were under weight (BMI less than 18kg/m2)

have an osteoporosis. Moreover (1.3%) of them who were obese (BMI more

than 30) have femoral osteoporosis and (4%) of them have lumber osteoporosis.

The study found negative relationship between decreasing BMD of femoral and

BMI (p.0.02), decreasing in BMI, would lead to decrease in BMD results, this

was consistent with (Ravan et al, 1999), who said that people with low BMI

have a two-fold greater risk of bone loss comparing with those people with

normal or highest BMI .also (Shilbayeh , 2003) , she considered that BMI as

independent risk with low (BMD).

Page 93 of 129

The study results (Table 10) revealed that only (2.3%) of participants who

consumed low amount of dietary calcium, have normal result of femoral BMD,

while more than half of them (38.3%) who consume high amount of dietary

calcium have normal result of femoral BMD and (52%) of them have normal

result of lumber BMD.Also it was showed that there was no relationship

between calcium consumption and BMD as P value. (0.907),(0.78).

While the relationship between milk consumption and BMD in (Table

11), showed that only (2.3%) of participants who never drank milk have femoral

osteoporosis and (3.3%) of them have lumber osteoporosis, while just (1%) of

participants who drank one glass daily have femoral osteoporosis and (3.3%) of

them have lumber osteoporosis, also it was showed that there was a relationship

between milk consumption and BMD in lumber site as P value (0.003) , which

consistent with (Wadolowska et al., 2013) who found in their study that women

with high consumption of dairy products include milk have regular BMD. Also

(Murphy, Khaw, May & Compston, 1994), found that milk consumption was a

significant independent predictor of BMD at both lumber and femoral in woman

who their age was up to 25.

Regarding the relationship between sun exposure and BMD as showed in

(Table 12) , it showed that only (1.7%) of participants who exposed all body to

sun, have femoral osteoporosis, while just (1.7%) of them have lumber

osteoporosis, the results also showed that there was no relationship between sun

exposure and BMD (P.0.27) ,(P.0.84) . which was disagree with,(Zhen, Liu,

Guang, Zhao and Tang, 2015), who found that sun exposure was considering

protective factors for osteoporosis , also, (Sato , Metoki , Iwamoto , and Satoh ,

2003) showed that the participants in their study who were exposed to sun light

their BMD increased by (3.1%) . These results came different of other studies

might be affected by factors such as different culture, religious , most of

Page 94 of 129

participants reported that they exposed just hands and face and little of them

reported that they exposed all body, also there was no specific tool to measure

amount of sun exposure might be affected on result .

The study results (Table 13) showed that (2.7%) of participants who

exposed to sun less than 30 min have a femoral osteoporosis and (5.3%) of them

have lumber osteoporosis, while (1.7 %) of participants who don’t expose to sun

have femoral osteoporosis and (2.7%) of them have lumber osteoporosis, it was

showed that it was no relationship between duration of sun exposure and BMD,

as P value (0.81), (0.83).

According to the number of parity and BMD relationship (Table 14)

results showed that less than of one third of the participants (29%) of

participants who have (3-5) children, have normal result of femoral BMD and

only (9%) of them who have no children, have normal result of femoral and

lumber BMD , while it was showed that there was no relationship between

number of parity and BMD results on both side femoral and lumber (P.158)

(P.051) which it variance with (Stevenson, Lees, Devenport, Cust and Ganger,

1989) ,those who found that null parity women had high risk for osteoporosis in

relation to decrease in BMD. Also (Murphy, Khaw, May and Compston ,1994)

indicated that there was a positive between parity and BMD by each parity live

increased the BMD by 1% . The study results might be affected due to small

number of study sample.

According to cheese consumption and BMD , (Table 15) showed that just

(1.3%) of them did not consume cheese have normal result of femoral BMD,

and (2.3%) of them who consumed one piece daily have femoral osteoporosis

and there was no significant relationship between amount cheese consumption

and BMD. which it not consistent with (Wadolowska et al., 2013) who found in

their study that women with high consumption of dairy products include cheese

Page 95 of 129

have normal BMD results also not similar with (Keramat et al, 2008) in India,

who found that regular consumption of cheese was categorized as protective

factors for osteoporosis in postmenopausal women , the results may vary due to

the amounts of cheese in piece not specific in grams, also due to the number of

sample .

Regarding amount of soft drink consumption and BMD, (Table 16)

showed that only (1.3 %) of them did not drank soft drink have femoral

osteoporosis and it found that there was a positive relationship between soft

drink and decreasing femoral BMD results (p.021), this consistent with

(Costa et al , 2015 ), who found that the absence of soda intake were

categorized under protective factors for osteoporosis.

Moreover about yogurt consumption and BMD (Table 17) showed that

(28.7%) of participants who consumed (1-3) glass per week have a normal

result of femoral BMD, also the results found that there was no significant

relationship between amount yogurt consumption and BMD (P.0.86),(P.0.89).

This results were not similar with , (Wadolowska et al., 2013) who found in

their study that women with high consumption of yogurt have normal BMD ,

may due to variation between amount in yogurt in milliliter and the small

number of sample, also there was not specific measurement tool to measure

amount of yogurt.

According to physical exercise and BMD, (Table 18) showed that just

(9.7%) of them who did not perform exercise have lumber osteoporosis, also it

was indicated that there was a significant relationship between duration of

exercise in minute and BMD of lumber (P 0.01), and this consistent was with (.

Kröger ,Tuppurainen , Honkanen, Alhava and Saarikoski, 1994), Who found

that low physical activity was contributed in lowering BMD results, and

(Keramat et al, 2008) were considered that exercise as protective factor for

Page 96 of 129

osteoporosis in postmenopausal women in India. Also in British women,

(Stevenson, Lees, Devenport, Cust and Ganger, 1989) they found lack of

regular exercise affect BMD results.

Moreover about smoking status and BMD, (Table 19) showed that more

than half (54.3%) of participants who don't smoke, have normal result of

femoral BMD and less than half (47.3%) of them have normal result of lumber

BMD. While just (3%) of participants who smoke one to ten cigarettes have

normal result of femoral and lumber BMD. Also it was indicated that there was

a positive relationship between number of smoked cigarettes and decreasing

BMD (P.0.019). This finding was agreed with (Costa et al., 2015) and

(Shilbayeh, 2003), they were considered the smoking as a risk factor of

osteoporosis.

In relation to status of period of participants and their BMD , (Table 20)

showed that quarter (25.7%) of participants who have regular menstrual period,

have normal result of femoral BMD, also (24%) of them have normal result of

lumber BMD. While (21.3%) of them who were menopause have normal result

of femoral and lumber BMD, also It was found that there was a relationship

between status of period and BMD as P value (0.000) .And this result went at

same line with ( Kröger ,Tuppurainen , Honkanen, Alhava and Saarikoski,

1994) who found that menopause status have a major effect on BMD.

The relationship between menopause period of participants and their

BMD as (Table 21) showed that (4.4%) of participants who were more 3 year

menopause have femoral osteoporosis and (8.7%) of them have lumber

osteoporosis. It indicated that there was a positive relationship between

menopause period and decreasing BMD on both side as P value (0.000) which

Page 97 of 129

was similar with (Corina, Vulpoi and Branisteanu, 2012) who found that the

BMD in postmenopausal women were lower than in premenopausal women.

The relationship between breast feeding and BMD as (Table 22) showed

that just (4%) of participants who did breastfed to more than 6 children have

normal result of femoral BMD and (3%) of them have normal result of lumber

BMD. While (12%) of participants who did fed to (1-3) children have normal

result of femoral BMD and (11.4%) of them have normal result of lumber

BMD. It was also showed that there was positive relationship between numbers

of breast fed children and decreasing BMD (P.0.003) , (P.0.042). These results

were agreed with (Okyayaet al 2013) who found that Prolonged breast-feeding

period per child > 1 year was the greatest risk factor for osteoporosis.

As (Table 23) results showed that (16%) of participants who have a

family history of osteoporosis, have normal result of femoral BMD and (12.2%)

of them have normal result of lumber BMD. While less than half (42.5%) of

participants who have not family history of osteoporosis, have normal result of

femoral BMD and more than one third (39.8%) of them have normal result of

lumber BMD. It was also showed that there was no correlation between family

history of participants and their BMD results on both side femoral and lumber

(P.366) , (P.121) , this was similar with (Shilbayeh, 2003) results, she was

considered that family of osteoporosis were not independent factors for

osteoporosis among Jordanian women .

According to usage of hormonal tablet and BMD, (Table 24) results

showed that just (0.7%) of participants who used hormonal tablet have femoral

osteoporosis and (2.3%) of them have lumber osteoporoses. While (4.7%) of

participants who did not use hormonal tablet, have femoral osteoporosis and

(10%) of them have normal lumber osteoporosis. It was also showed that there

Page 98 of 129

was no relationship between uses of hormonal tablet and BMD on both side,

this results was disagreed with (Stevenson, Lees, Devenport, Cust and Ganger,

1989) who found that uses of oral contraceptives were risk factor for lowering

BMD results, however (Shilbayeh, 2003) considered that duration of hormone

replacement therapy (HRT) were correlated with BMD , the results study may

be affected by small size of sample and lack awareness of benefit usage of

hormonal tablet and different culture .

According to Vit D and BMD ,(Table 25) results showed that that half

(51.6%) of participants who were chosen for Vitamin D test and who have

normal level of Vitamin D (20-50), have normal result of femoral BMD, while

(38.6%) of them have normal result of lumber BMD. On other hand , (13.8%)

of them who have deficiency in Vitamin D ( less than 19) , have normal result

of femoral BMD and (11.4%) of them have normal result of lumber BMD. Also

it was found that there was no relationship between Vit D and BMD on both

side femoral and lumber site , P (.561) (.775). These results was consistent

with study conducted in China (Zhen, Liu, Guang, Zhao and Tang, 2015) their

study indicated that reduced in 25(OH) D levels were not primary related with

an increased osteoporosis risk. And these finding disagree with study conducted

in Japan (Sato, Metoki, Iwamoto, and Satoh, 2003) their study indicate that the

BMD affected by Vit D and sun exposure. There were many factors may affect,

the sun was one of major sources for Vit D and this effect on BMD such as

duration of sun exposure, In this study the most of participants reported that

areas that exposed to sun were hands and face this due to culture and religious

in the Palestinian society, moreover the participants were women and they

wearing long clothes which cover all of body.

According to estrogen and BMD, (Table 26) results showed that just

(0.3%) of participants who were pre-menopause and who have normal level of

estrogen hormone (15-350), they have femoral osteoporosis, while (0.7) of them

Page 99 of 129

have lumber osteoporosis. In addition, there was just (3.3%) of participants

who were post-menopause and who have abnormal result of estrogen hormone,

they have femoral osteoporosis, while (7%) of them have lumber osteoporosis.

Also it was showed that there was negative relationship between estrogen and

decreasing BMD (P.0.00) , this was consistent with study conducted in USA

(CDC, 1998), which indicated that most estrogen-deficient women in the United

States who had femoral osteoporosis were ignorant of having this condition,

(CDC, 1998). Also this at the same line of study conducted in Japan ( Orimo,

Fujita, Yoshikawa, Hayano , and Sakurada , 1970 ) showed that administration

of conjugated estrogens significantly protected against the decrease in the bone

density and the cortical wideness of the femurs.

Conclusion

This study was designed to investigate the factors that affecting on BMD

including estrogen and vitamin D among women who above 35 years old in

Nablus city, except the women in lactation or pregnancy period. DXA Device,

measured BMD and vitamin D and estrogen were measured by blood serum

analysis and other factors were measured by questionnaire.

After the analysis was done on SPSS and according to WHO criteria, it

showed that (52%) of the participants have normal results of BMD, (35.7%) of

Page 100 of 129

them have osteopenia and (12.3%) have osteoporosis. At femoral site, it showed

that (58.7%) of the women have osteoporosis, (36%) have osteopenia and

(5.3%) have osteoporosis.

The osteopenia percentage was prominent and high among participants in

general, the highest percent of it was in women at age (>55) year. The normal

Estrogen serum level according to status of period was as following: (76%) of

women who have regular period, their results were (15-350), also (72%) of

women who have irregular period their results were (15-350), in addition (35%)

of menopause women, their results were (less than 10). Moreover the highest

age group has deficiency in Vitamin D is (45-44).

The study showed that there were risk factors affecting on BMD, these

factors were elderly women, low BMI, smoking, soft drink, breast-feeding,

menopause and post-menopause. Also showed that there was a relationship

between estrogen level and BMD, however no relationship between vitamin D

and BMD.

Page 101 of 129

Recommendations

1. Follow up and early screening for non-menopausal women and women

with past family history with osteoporosis to prevent osteoporosis.

2. It is recommended to expose the hands and face to the sun daily for 10 to

15 minutes during the middle of the day to get optimal Vitamin D. Based

on literature review, get attention on vitamin D to prevent consequences

of osteoporosis ,even if it was no relation between calcuim ,vitamin D

and BMD.

3. Exercise 75-150 minutes for 2 or more time per week to keep normal and

healthy bone.

4. Calcium intake for pre-menopause (<50 year) suggested to intake 1000

mg/day and 1200 mg/day for postmenopausal women. Based on literature

review , get attention on calcium to prevent consequences of osteoporosis

,even if it was no relation between calcium, and BMD

5. Increase health education about limitation of soft drink intake and

smoking in primary health care and among schools

6. Increase awareness about the importance for breast-feeding as protective

from osteoporosis.

7. Maintain as possible ideal weight not less and not more BMI (18-24.9).

Page 102 of 129

8. It advised to provide the diagnosis of bone density device DXA in

primary health care clinic in Palestinian society.

9. More studies must investigate the relationship between vitamin d and

BMD.

Limitations

1. Time to conduct the study and collect the data was limited.

2. Small sample size, which may expose the results to bias.

3. Using convenience method rather randomize due to restrictive policies of

the association

Page 103 of 129

References (APA style)

1. Agrawal, T. &Verma, A.K. (2013). Cross sectional study of osteoporosis

among women. Med J Armed Forces India.69(2): 168–171.[Pmc

Articles] .

2. Aloia, J.F., Cohn, S.H., Vaswani, A, Yeh, J.K., Yuen, K. & Ellis, K.

(1985) . Risk factors for postmenopausal osteoporosis. The American

Journal of Medicine. 78, (1) p95–100. [PubMed]

3. Avenell, A.,Gillespie, W.J., Gillespie, L.D,& O’connell,D.(2005).

Vitamin D and vitamin D analogues for preventing fractures associated

with involutional and post-menopausal osteoporosis. Cochrane Database

Syst Rev;(2):CD000227.

4. Babatunde, O., Brinkley,J. &Brenda J. (2015). Too Young to Care -

Gender and Athletic Status Differences in the Knowledge of Osteoporosis

Risk Factors among Undergraduates. Journal of Nutrition Education and

Behavior.47(5), p403-486.[Articles Free]

5. Bischoff, H.A. (2012) .Which vitamin D oral supplement is best for

postmenopausal women. current osteoporosis reports.10(4):251-7

[PubMed]

6. Cauley,J.A. , Cummings,S.R. , Black , D.M. ,Mascioli , S.R.&Seeley DG.

(1990). Prevalence and determinants of estrogen replacement therapy in

elderly women. American Journal of Obstetrics and Gynecology.163(5)

p1438–1444.

Page 104 of 129

7. CDC.Centers for Disease Control and Prevention. (2012). CDC Second

Nutrition Report Vitamin D deficiency closely related to race/ethnicity.

Retrieved at 9 November at : [CDC]

8. CDC.Centers for Disease Control and Prevention. (2015).Genomics,

Family History & Osteoporosis. Retrieved at 11 Novemver: [CDC]

9. Chan ,M.F.&Ko CY. (2006).Osteoporosis prevention education programs

for women. Advancing nurse .54(2):159-70 [PubMed]

10.Chapuy, M.C. ,Arlot, M.E., Duboeuf, F., Brun ,J. , Crouzet, B. , Arnaud,

S., Delmas ,P.D. &Meunier ,P.J.(1992). Vitamin D3 and calcium to

prevent hip fractures in the elderly women. New England Journal of

Medicine, 327(23):1637-42 [PubMed]

11.Chen ,S.J. ,Lin,C.S. , Lin, C.L. & Kao C.H. (2015). Osteoporosis Is

Associated With High Risk for Coronary Heart Disease. Medicine

(Baltimore). ; 94(27): e1146. [Pubmed]

12. Clinic, D.A. (2010).Denver arthritis clinic. Osteoporosis questionnaire.

available at

http://denverarthritisclinic.com/uploads/images/Resources/FORM-

OSTEOQUESTIONNAIRE_003.pdf

13.Copenhagen Consensus Conference. (1990).What Is Osteoporosis?

Available at: [PubMed]

14.Corina, M.,Vulpoi, C. &Brănişteanu,D. (2012). Relationship between

bone mineral density, weight, and estrogen levels in pre and

postmenopausal women. National Library of MedicineNational Institutes

of Health. 116(4):946-50.[Bio Med Lab]

Page 105 of 129

15.Costa ,A.L. , Silva ,M.A . , Brito,L.M. , Nascimento , A.C, Barbosa,

J.E . , Bezerra,G.F. , Viana,G.M. , Muniz ,W.E. ,

Vidal ,F.C .&NascimentoMD . (2015). Osteoporosis in primary care: an

opportunity to approach risk factors. Rev Bras Reumatol. S0482-

5004(15)00070. [Pubmed]

16. Davidson, M.R. (2003) .Pharmacotherapeutics for osteoporosis

prevention and treatment. Journal of Midwifery and Women’s Health.

48(1),39-52.Retrieved at : [medscape]

17. Davis, JL. (2009). the Effects of Smoking on Bone Health; Living with

Osteoporosis. WebMD Home .Retrieved at: [webmed]

18.El Maataoui, A. ,El Maghraoui,A. , Biaz, A. , Elmachtani, S.I. , Dami,

A. ,Bouhsain, S. , Mounach, A. , Chabraoui, L .&OuzzifZ .(2015).

Relationships between vertebral fractures, sex hormones and vitamin D in

Moroccan postmenopausal women. BMC Womens Health. 13;15:41.[Bio

Med Central]

19. El Maghraoui,A .(2012).Interpreting a DEXA Scan in Clinical

Practice .Rheumatology Department, Military Hospital Mohammed V,

Rabat, Morocco .Reviewed at :

http://cdn.intechopen.com/pdfs-wm/26674.pdf

20.El Maghraoui,A., ElMaataoui,A., Biaz, A. , Elmachtani,S.I. , Dami,

A. ,Bouhsain,S. , Mounach,A. , Chabraoui,L .&Ouzzif , Z .(2015).

Relationships between vertebral fractures, sex hormones and vitamin D in

Moroccan postmenopausal women. BMC Women Health. 13;15:41.[Bio

Med Central]

Page 106 of 129

21.El-Tawab, S., Saba, E.,Elweshahi, H.&Ashry, M.(2015). Knowledge of

osteoporosis among women in Alexandria.The Egyptian

Rheumatologist .doi:10.1016/j.ejr.2015.08.001.[Sciencedirect]

22. Family health guide.(2011) .menopause .Available

at:http://www.familyhealthguide.co.uk/menopause.html

23. Gourlay, M.L.,Fine,J.P., Preisser, J, S.,May, R.C.,Chenxi,

L.,Lui,L.Y.,Ransohoff, D.F.,Cauley, J.A. &Ensrud, K. E.(2012). Bone-

Density Testing Interval and Transition to Osteoporosis in Older Women.

New England Journal of Medicine. 366(3): 225–233[PubMed]

24. Grob, G.N. (1931). Aging bones: a short history of osteoporosis.p5. Johns

Hopkins Biographies of Disease.

https://www.goodreads.com/book/show/18639541-aging-bones

25. Health wise.(2014). Bone Density. WebMD Home Osteoporosis Health

Center ,Assessed on 22th October, Retrieved at

http://www.webmd.com/osteoporosis/bone-mineral-density-test

26. Henry, G. (1918). Anatomy of the Human Body. Osteology. available at

http://www.bartleby.com/107/18.html

27. Hillier ,T.A. , Rizzo ,J.H. , Pedula ,K.L. , Stone, K.L. ,

Cauley ,J.A. ,Bauer, D.C .&Cummings, S.R .(2003).Null parity and

Fracture Risk in Older Women: The Study of Osteoporotic

Fractures .Bone and Mineral Research .18(5) ,893–899, [PubMed]

Page 107 of 129

28.Hannon, C.& Murphy, K.(2007). A survey of nurses and midwives’

knowledge of risks and lifestyle factors associated with osteoporosis.

Journal of Orthopedic Nursing. 11(1):30-37.[Article]

29.Hernlund,E.,Svedbom,A. , Ivergård,M. , Compston,J. , Cooper,C. ,

Stenmark ,J. ,McCloskey,E.V. , Jönsson,B. &Kanis, J. A.

(2013).Osteoporosis in the European Union: medical management,

epidemiology and economic burden.Archives of Osteoporos .8(1-2): 136.

[PubMed] .

30.Humadi ,A. , Alhadithi, R.H. & Alkudiari ,S.I. (2010). Validity of the

DEXA diagnosis of involutional osteoporosis in patients with femoral

neck fractures. indian journal of orthopaedics. 44(1):73-8..[Free Articles]

31.IOF.International Osteoporosis Foundation. (2015).Osteoporosis

&Musculoskeletal Disorders - Osteoporosis - Prevention .Retrieved at

12th November at: http://www.iofbonehealth.org/osteoporosis-

musculoskeletal-disorders/osteoporosis/prevention/calcium

32.IOF.International Osteoporosis Foundation. (2015). Osteoporosis &

Musculoskeletal Disorders .Osteoporosis. Retrieved at 21 October. from :

http://www.iofbonehealth.org/

33.IOF.International Osteoporosis Foundation. (2015). Osteoporosis &

Musculoskeletal Disorders; Osteoporosis; Prevention. VITAMIN D.

Retrieved at 8th November From:

http://www.iofbonehealth.org/osteoporosis-musculoskeletal-disorders/

osteoporosis/prevention/vitamin-d

Page 108 of 129

34.Janiszewska, M.,Kulik, T.,Dziedzic, M.A. &Żołnierczuk-Kieliszek D.

(2015). Chosen risk factors for osteoporosis and the level of knowledge

about the disease in peri- and postmenopausal women. Menopause

review. 14(1):27-34.[Pubmed]

35. Karlsson, M.K.,Nordqvist, A.&Karlsson , C. (2008). Physical activity

increases bone mass during growth. Food Nutr Res.; 52: 10.3402 .[Pmc

Articles]

36.Keramat,A., Patwardhan,B. , Larijani, B. , Chopra ,A., Mithal,A.,

Chakravarty,D., Adibi, H .&Khosravi,A .(2008). The assessment of

osteoporosis risk factors in Iranian women compared with Indian

women.BMC Musculoskeletal Disorders.9(28).[BioMed Central Ltd]

37.Khorsandia, M.,Hasanzadehb, L.&Ghobadzadehc, M. (2012).

Assessment of Knowledge and Self-Efficacy in Achieving Osteoporosis

Prevention Behaviors among High School Female Students. Procedia

Social and Behavioral Sciences.46; 4385–4388.[Science Direct]

38. Kim, Y., Kim,J.H. &Cho, D.S. (2015). Gender difference in osteoporosis

prevalence, awareness and treatment: based on the Korea national health

and nutrition examination survey 2008~2011. J Korean Acad Nurse.

(2):293-305.[Pubmed]

39. Kleerekoper,M. , Brienza,R.S. , Schultz, R.L.&Johnson ,C.C. (1991).

Oral Contraceptive Use May Protect Against Low Bone Mass. Jama

Internal Medicine, Arch Intern Med. 151(10):1971-1976 .[Article]

Page 109 of 129

40.KrögerH, M. , Tuppurainen ,M., Honkanen ,R., Alhava ,E .&Saarikoski ,

S .(1994) . Bone mineral density and risk factors for osteoporosis a

population-based study of 1600 peri menopausal women. Calcified

Tissue International . 55, (1) p1-7.[Springer article]

41.Krucik, G. (2014).Osteoporosis; Osteoporosis Symptoms. available

at :Retrieved at http://www.healthline.com/health/osteoporosis-

symptoms#Overview1

42.Lufkin ,E.G. , Heinz ,W. , Wahner, M.D. , O'Fallon, W.M. , Hodgson ,

S.F. , Kotowicz , M.A. , Lane, A.W. ,Judd ,H. L. , Caplan,R.H .& Riggs,

L.B. .(1992). Treatment of Postmenopausal Osteoporosis with

Transdermal Estrogen. Annals of internal medicine.117 (1):1-9[Free

Article]

43. Makhdoom,A.,Rahopoto,M. , Siddiqui, K.A. &Qureshi ,G.A. (2014).

Early Detection of Osteoporosis by Dual Energy X-ray Absorptiometry.

Pakistan Journal of Medical Sciences.30 (6): 1265–1269.[PMC Articles]

44. Manring, M.M.& Calhoun, J.H .(2011) .Biographical Sketch: Fuller

Albright,ClinOrthopRelat Res .469(8): 2092–2095 [PubMed]

45.Mayo Foundation for Medical Education and Research. (2015).

Estrogens, Estrone (E1) and Estradiol (E2), Fractionated,

Serum .available at .http://www.mayomedicallaboratories.com/test-

catalog/Clinical+and+Interpretive/84230]

46.Mayo Medical. (2013).vitamin D testing the Laboratories

Difference.avilableat.http://www.mayomedicallaboratories.com/articles/

vitamind/pfriendly.html

Page 110 of 129

47. Miura, S.,Saavedra, O.L.&Yamamoto .S. (2008). Osteoporosis in urban

post-menopausal women of the Philippines: prevalence and risk factors.

Arch Osteoporosis. 3(1-2): 17–24.[Springer]

48.Murphy ,S. , Khaw,K.T. , May ,H .&Compston, J.E. (1994). Milk

consumption and bone mineral density in middle aged and elderly women

.British Medical Journal .308:939.

49.Murphy,S. ,Khaw, K.M. ,May, H.&Compston ,J.E. (1994) .Parity and

bone mineral density in middle-aged women .Osteoporosis

International.4(3):162-166.[Springer article]

50.Mayo Foundation For Medical Education And Research .(2013).vitamin

D testing; The Mayo Medical Laboratories Difference .

http://www.mayomedicallaboratories.com/articles/vitamind/pfriendly.htm

l

51. NIH. National Institute Health. (2015).Osteoporosis ;Women; Pregnancy,

Breastfeeding, and Bone Health .Retrieved at 6th November:

http://www.niams.nih.gov/health_info/Bone/Bone_Health/Pregnancy/def

ault.asp

52. NOF. National Osteoporosis Foundation. (2013).Learn about

Osteoporosis, Bone Basics. Assessed on 20th October, Retrieved

at :http://nof.org/learn/bonebasics

53. NOF.National Osteoporosis Foundation. (2014).Making a Diagnosis.

Retrieved at 10th November at : http://nof.org/articles/8

Page 111 of 129

54. NOF.National Osteoporosis Foundation .(2012).Calcium and Vitamin D:

What You Need to Know .Retrieved at 5th November

at :http://nof.org/calcium

55. NOF.National Osteoporosis Foundation. (2014).What is Osteoporosis?

Retrieved at 11thNovemberathttp://www.nof.org/articles/7

56.Okyay, D.O.,Okyay, E.,Dogan,E. , Kurtulmus, S. , Acet, F. , Taner, C.E.

(2013). Prolonged breast-feeding is an independent risk factor for

postmenopausal osteoporosis. National Library of MedicineNational

Institutes of Health. 74(3):270-5 .[Pubmed]

57.Orimo, H.,Fujita, T.,Masaki, Y.,Hayano, K.&Toyozo, S. (1970). Effect of

Estrogen on Immobilization Osteoporosis. Endocrinology.88 (1)

onilne1945-7170. Available at

http://press.endocrine.org/doi/abs/10.1210/endo-88-1- 102?

journalCode=endo

58.Osteoporosis. (2007). Webster’s Timeline History. Retrieved at 24th

October from http://sciencebeta.com/history-osteoporosis/

59.Pacheco ,E.M. , Harrison ,E.J. , Ward, K.A. , Lunt, M . & Adams, J.E.

(2002). Detection of osteoporosis by dual energy X-ray absorptiometry

(DXA) of the calcaneus: is the WHO criterion applicable? .Calcified

tissue international. 70(6):475-82.[PuBmed]

60.Pasco, J,A., Henry, M.J. , Nicholson, G.C. , Sanders, K,M.& Kotowicz,

61.PCBS. (2009) . (2010) .Palestinian Central Bureau of Statistics .Available

at: www.pcbs.gov.ps/default.aspx

Page 112 of 129

62. PCBS. (2010) .Palestinian Central Bureau of Statistics .Available at:

www.pcbs.gov.ps/default.aspx

63.PCBS. (2011) .Palestinian Central Bureau of Statistics .Available at:

www.pcbs.gov.ps/default.aspx

64. PCBS. (2012) .Palestinian Central Bureau of Statistics .Available at:

www.pcbs.gov.ps/default.aspx

65.PCBS. (2013).Palestinian Central Bureau of Statistics. Statics. Reviewed

at : http://www.pcbs.gov.ps/

66.Prior, J.C., Kirkland, S.A. , Joseph, L. , Kreiger, K. , Murray ,T.M. ,

Hanley, D.A. , Adachi, J.D. , Vigna , Y.M. , Berger, C., Blondeau,L. ,

Jackson, S.A.&Tenenhouse, A. (2001) . Oral Contraceptive Use and

Bone Mineral Density in Premenopausal Women: Cross-sectional,

population-based data from the Canadian Multicenter Osteoporosis

Study. CMAJ 165(8):1023-1029.

67.Ravan,P. , Cizza, G. , Bjarnason ,N.H. , Thompson, D. , Daley, M. ,

Wasnich, R.D. , McClung, M. , Hosking, D. , Yates, A.J .

&Christiansen ,C.(1999).Low body mass index is an important risk factor

for low bone mass and increased bone loss in early postmenopausal

women. Early Postmenopausal Intervention Cohort (EPIC) Study Group.

Journal of Bone and Mineral Research. 14(9),1622-1627.[PubMed]

68.Salari ,P.&Abdollahi, M. (2014).The Influence of Pregnancy and

Lactation on Maternal Bone Health: A Systematic Review. Family and

Reproductive Health, 8(4), 135–148[PubMed]

69.Sato ,Y. , Metoki, N. , Iwamoto, J. & Satoh ,K .(2003) .Amelioration of

osteoporosis and hypovitaminosis D by sunlight exposure in stroke

patients.American academy of neurology.61(3):338-342 .[Free Articles]

Page 113 of 129

70. Shackelford, L.C., LeBlanc ,A.D. , Driscoll ,T.B. , Evans, H.J. ,

Rianon ,N.J. , Smith ,S.M. , Spector, E. , Feeback ,D.L.&Lai ,D.l .(2004).

Resistance exercise as a countermeasure to disuse-induced bone loss.

Journal of Applied Physiology. 97(1):119-29. [PubMed]

71.Shilbayeh,S .(2003) . Prevalence of osteoporosis and its reproductive risk

factors among Jordanian women: a cross-sectional study. Osteoporosis

International. 14(11):929-40

72. Soroko,S.B. , Barrett,C.E. , Edelstein,S.L.&Kritz,S.D.(1994) .Family

history of osteoporosis and bone mineral density at the axial skeleton: the

Rancho Bernardo Study. Journal of Bone and Mineral Research. 9(6),

761-769[JBMR]

73. Specker, B. &Binkley, T. (2003).Randomized trial of physical activity

and calcium supplementation on bone mineral content in 3- to 5-year-old

children. Bone Miner Res .18(5):885-92. [PubMed]

74. Stevenson, J.C., Lees, B., Devenport,M. ,Cust, M.P.& Ganger, K.F.

(1989).Determinants of bone density in normal women: risk factors for

future osteoporosis? . British Medical Journal.298 doi:

http://dx.doi.org/10.1136/bmj.298.6678.924

75.Stolarczyk A., Horvath, A., Szczechura, M. ,

Kamińska,M .&Dziechciarz,P.(2014). High prevalence of vitamin D

insufficiency in community-dwelling postmenopausal Polish

women .Menopause review. 13(5):289-92.[Journal Article]

Page 114 of 129

76.Vered, I.,Werner, P. &Shemy, O. (2008). Nurses' knowledge and

perceptions about osteoporosis: a questionnaire survey. International

journal of nursing studies. 45(6):847-54.[PubMed]

77.Vitamin D council.(2010) .How do I get the vitamin D my body needs?

available at :https://www.vitamindcouncil.org/about-vitamin-d/how-do-i-

get-the-vitamin-d-my-body-needs/

78.Wadolowska, L. , Sobas,K. ,Szczepanska,J.W. , Slowinska,M.A. ,

Matyasik,M.C.&Niedzwiedzka ,E .(2013) . Dairy Products, Dietary

Calcium and Bone Health: Possibility of Prevention of Osteoporosis in

Women. Nutrients. 5(7): 2684–2707.[Mdpi]

79.WebMD. (2014).Estrogens. Women's Health. reviewed at 6 November

available at : http://www.webmd.com/women/estrogens

80. Whitcomb,B.W. , Bodach,S.D. , Mumford ,S.L. , Perkins, N.J. , Trevisan,

M. , Wende,J.W. , Liu,A. &Schisterman ,E.F .(2010) .Ovarian function

and cigarette smoking in the Bio Cycle Study. HHS Author Manuscripts.

24(5): 433–440.[PubMed]

81. WHO. World health organization. (1994). Assessment of Fracture Risk

and its Application to Screening for Postmenopausal Osteoporosis.

Report of a WHO study Group.  World Health Organ Technical Report

Series. 1994; 843:1-129. [PubMed]

82.WHO. World health organization. (2004). Scientific group on the

assessment of osteoporosis at primary health care level

[http://www.who.int/chp/topics/Osteoporosis.pdf ]

Page 115 of 129

83. WHO. (2010).World Health Organization. Global recommendations on

physical activity for health.

Retrieve

dhttp://apps.who.int/iris/bitstream/10665/44399/1/9789241599979_eng.p

df

84.WHO. (2012). WHO Criteria for Diagnosis of Osteoporosis. World

Health Organization available

at:http://www.4bonehealth.org/education/world-health-organization-

criteria-diagnosis-osteoporosis/

85. Wilkins, C.H. (2007). Osteoporosis screening and risk management.

Clinical Intervention in Aging 2(3):389-39[PubMed]

86.Xu, J. , Sun, M. , Wang ,Z. , Fu, Q. , Cao ,M. , Zhu, Z. , Meng, C. , Yan,

Y. , Mao, J. , Tao ,H. , Huang, X. , Lin, Z. , Yang, T.& He, W.(2013).

Awareness of osteoporosis and its relationship with calcaneus

quantitative ultrasound in a large Chinese community population. Clinical

Intervention Aging. 8:789-96.[Pubmed]

87.Zack,M.k. (2002). Reliability and Validity of Body Composition and

Bone Mineral Density Measurements by Dxa .p 9-10. Available at

[Http://Scholar.Lib.Vt.Edu/Theses/Available/Etd-04172002-123509/Unre

stricted/Thesis.Pdf]

88. Zhen, D. , Liu ,L. , Guan ,C. , Zhao, N . Tang,X .(2015). High prevalence

of vitamin D deficiency among middle-aged and elderly individuals in

northwestern China. Europe.71:1-6.[Pubmed]

Page 116 of 129

89.Zimmerman, M. &Snow, B. (2012) .An Introduction to Nutrition; Risk

Factors for Osteoporosis .Chapter 9: Nutrients Important for Bone Health.

Retrieved at http://2012books.lardbucket.org/books/an-introduction-to-

nutrition/index.html

Page 117 of 129

Annex I (questionnaire)

الوطنية النجاح جامعةالصحية والعلوم الطب كلية

والقبالة التمريض دائرة

المشاركة :عزيزتيالنجاح جامعة في والقبالة التمريض كلية في تجرى سوف بحثية دراسة في للمشاركة مدعوة أنت

بعنوان تخرج كمشروع لتقديمه : الوطنية

في " النساء بين دال وفيتامين العظام كثافة نسبة وقياس االستروجين فحص مستوى بين العالقة

نابلس مدينة في االعمار " مختلففقراتها عن اإلجابة منك يرجى الدراسة، موضوع حول المعلومات لجمع االستبانة هذه صممت وقد

فقط العلمي للبحث إال تستخدم ال لنا ستقدمينها التي المعلومات بأن لك ومؤكدين تعاونك، لك . شاكرين

ة/ :الباحث

.........................

وأهدافه البحث :وصففي تساعد سوف شأنها من التي األعمار، مختلف في النساء على استبيان توزيع إلى الدراسة تهدفوفقا العظام بهشاشة لإلصابة معرضة عمرية فئة أكثر النساء تجعل بدورها التي الخطر عوامل تحديد , لفحص دم عينة أخذ يتم سوف كما عمرية مرحلة كل في لها تتعرض التي وهرمونية جسدية لتغيرات

( الهرمونات ( نسبة لتحديد الظهر ألسفل أو الورك للحوض أشعة وصورة دال وفيتامين االستروجينهذه بين العالقة وتحديد العظام هشاشة مرض تشخيص في تساعد سوف التي العظام كثافة ونسبة

نابلس مدينة في النساء بين ومقارنتها االختباراتالدراسة هذه عن الناتجة :الفوائد

االعمار مختلف في النساء بين العظام وكثافة دال وفيتامين االستروجين هرمون نسبة قياس النساء بين العظام هشاشة حدوث في المساعدة الخطر عوامل وتحديد كشف

Page 118 of 129

عظام دكتور الى أحالتها يتم سوف العظام بهشاشة المشاركات أحد اصابة الى تشير نتائج اي

والفيتامين , االستروجين لفحص بالنسبة وكذلك الصغيرة االيدي جمعية في العالج لتلقي مختص

الجمعية في نسائية دكتورة الى تحويلها يتم سوف دال الدراسة في المشاركة في يرغب من لكل مجانا مؤمنة االشعة وصورة الدم عينة فحص تكاليف

, النساء من عينةاخرى اخذ يتم فسوف االنسحاب قررت او البحث هذا اإلشراكفي رفضك حالة في

المشتركة : موافقة

اسئلتي على االجابة تمت البحث،ولقد هذا من والغرض المحتوى وفهمت هذااالستبيان قرأت . لقد , , الباحثين , ان اعلم وأني العلمي البحث هذا في المشاركة على اوافق مختارة حرة فأني لذلك وفقا

, شئت متى البحث هذا من االنسحاب في الحق ولي وقت اي في اسئلتي عن باإلجابة يقومون سوفالتاريخ المشتركة توقيع

________________ ________________

Page 119 of 129

)1 ________ : االسم) كغم) : ____ 2 ( الوزنسم) : ___ 3( الطول

فوق )55. ( 3سنة ) 54-45 .( 2سنة ) 44-35.( 1العمر) : 4 ( فما سنة) 5 : السكن) قرية. 3مخيم. 2مدينة. 1مكانمنزل. 2موظفة. 1المهنة) : 6 ( ذلك. 3ربة غيروالمعيشي) :7 ( االقتصادي من. 1الوضع شهريا 1000أقل شيكل

شهريا 1000-1999. 2 شيكلشهري 2000-2999. 3 شيكل

شهريا 3000اكثرمن. 4 شيكلاالجتماعية) : 8 ( الحالة

ارملة. 4مطلقة. 3متزوجة. 2عزباء. 1

؟) 9( جراحية عملية باجراء قمت ال. 2نعم. 1هلالتالية) :10( االمراض من مرض اي من تعاني هلالدم. 1 ضغطالسكري. 2 الدرقية. 3 الغدد امراضالروماتويدي. 4 المفاصل التهاب

ذلك. 5 غيرامراض. 6 يوجد ال؟) 11( التاليه المواضع أحد في الظهر في بألم تشعرين هلمسطحة. 1 أرض على الدرج. 2المشي مرتفع. 3صعود مكان الركوع. 4صعود اثناء

ألم. 5بالصالة يوجد ال؟) 12( التالية االوضاع أحد في المفاصل في بألم تشعرين هلمسطحة. 1 أرض على الدرج. 2المشي مرتفع. 3صعود مكان الركوع. 4صعود اثناء

ألم. 5بالصالة يوجد ال؟) 13( العظام هشاشة مرض من يعاني العائلة افراد من أحد لديك ال. 2نعم. 1هل

Page 120 of 129

المعلومات : األول القسم الشخصية

الوضع : عن معلومات الثاني القسموالجراحي الصحي

الحموالت) : 14( يوجد. 1عدد يساوي. 2ال أو من. 4 5-3. 3 2اقل 5اكثر

)15 : الوالدات) يوجد. 1عدد يساوي. 2ال أو من. 4 5-3. 3 2اقل 5اكثر

)16 : االجهاضات) يوجد. 1عدد يساوي. 2ال أو من. 4 5-3. 3 2اقل 5اكثر

سنة) :_____________ 17( الحيض بدء عند العمرعام) : 18( بشكل الشهرية الدورة من. 1طول .4يوم 28-24. 3يوم 24 -18. 2يوم 18اقل

من يوم 28اكثرالحالي) :19( الوقت في الشهرية الدورة تصفي كيف

منتظمة. 2منتظمة منقطعة. 3غير

)20: , منذ) كانت الشهرية الدورة انقطاع فترة منقطعة كانت اذاسنة. 1 من من. 3سنوات 3-1. 2اقل سنوات 3اكثرسنة) :______ 21 ( الدورة انقطاع عن عمرك كان كم

؟) 22( طبيعية رضاعة أطفالك بأرضاع قمت أطفال. 3ال. 2نعم. 1هل يوجد ال

)23 : أرضاعهم) تم الذي االطفال من. 3 ) 6-4. (2 ) 3-1. ( 1عدد أطفال. 4 6اكثر يوجد أرضع. 5ال لم

بها) : 24( باالرضاع قمت التي الفترة هي مامن. 1 سن - 6من. 2اشهر 6أقل سنة. 3اشهر من أطفال. 4اكثر يوجد الارضع. 5 لمالهرمونات) : 25( اقراص استخدمتي ال. 2نعم. 1هل

استخدامها) : 26( من الحمل. 1الغاية هرمونات. 2منع قط. 3استبدال استخدمها لم

الهرمونات) 27 ( استبدال الستخدام الزمنية المدة هي ما هرمونات استبدال باستخدام قمت اذاسنة. 1 من من. 3 3_1من. 2اقل قط. 4 3اكثر استخدمها لم

Page 121 of 129

واالمور : واالمراض االنجاب الثالث القسمبالنساء المتعلقة

الغذائي : النمط الرابع القسم

باالسبوع) : 28( للحليب تناولي ابدا. 1معدل الحليب أتناول باالسبوع) 3-1. ( 2ال . (3كأس

باألسبوع ) 6 - 4 يوم. 4كأس كل واحد كأس

الجبن) : 29( أبدا. 1أتناول الجبن أتناول باالسبوع) 3-1. (2ال باالسبوع ) 6-4. ( 3قطع قطع

يوم. 4 كل واحده قطعة

اللبن) : 30( ابدا. 1أتناول الحليب أتناول باالسبوع) 3-1. ( 2ال -4. ( 3كأس

باألسبوع ) 6 يوم. 4كأس كل واحد كأس

الغازية) : 31( المشروبات ابدا. 1أتناول الحليب أتناول باالسبوع) 3-1. ( 2ال كأس

باألسبوع ) 6 - 4. ( 3 يوم. 4كأس كل واحد كأس

غذائيا) : 32( مكمال الكالسيوم حبوب أبدا. 3أحيانا. 2دائما. 1أتناول

)33) د) فيتامين أبدا. 3أحيانا. 2دائما. Vitamin D :( 1أتناول

تدخنين) : 34( ال. 2نعم. 1هل

)35 : , التدخنين) نوع هو ما نعم االجابة كانت عادي. 1ان أدخن. 4كالهما. 3أرجيلة. 2دخان ال

باليوم) : 36( السجائر من. 3) 20- 10. ( 2) 10- 1. (1عدد أدخن. 4 20اكثر ال

Page 122 of 129

الرياضة : الخامسالقسم والحركة

)37 : يوميا) الرياضة بممارسة ال. 2نعم . 1اقوم

تمارسينها) : 38( التي الرياضة اخرى. 3ركض. 2مشي. 1نوع الرياضة. 4رياضة امارس ال

اليوم) : 39( خالل الرياضة من. 1مدة من. 3دقيقة 30. 2دقيقة 30اقل ال. 4دقيقة 30اكثرالرياضة امارس

باالسبوع) : 40( الرياضه بها أمارس التي االيام باالسبوع ) 3-1. (1عدد أيامباالسبوع) 6- 4. (2 يوم. 3ايام أبدا . 4كل الرياضة أمارس ال؟) 41( للشمس تتعرضين ال. 2نعم . 1هل

نعم , االجابة كانت اذالمدة) : 42 ( يوميا للشمس من. 1أتعرض من. 3دقيقة) 30. (2دقيقة 30أقل دقيقة 30اكثر

الشمس. 4 الشعة أتعرض ال؟) _______43 ( للشمس تتعرض التي الجسم مناطق هي وما

الطبية الفحوصات النتيجةاسماءاالستروجين( 44( فحص

العظام) ((45( كثافة DXAفحصدال) 46( فيتامين فحص

Page 123 of 129

: السادسالقسم

المخبرية الفحوصات

Page 124 of 129

Annex II Facebook event

Page 125 of 129

Annex III IRB approval latter

Page 126 of 129

Annex IV (consent form)

الوطنية النجاح جامعةالصحية والعلوم الطب كلية

والقبالة التمريض دائرةالمشاركة :عزيزتي

النجاح جامعة في والقبالة التمريض كلية في تجرى سوف بحثية دراسة في للمشاركة مدعوة أنت

بعنوان تخرج كمشروع لتقديمه : الوطنية

في " النساء بين دال وفيتامين العظام كثافة نسبة وقياس االستروجين فحص مستوى بين العالقة

نابلس مدينة في االعمار " مختلففقراتها عن اإلجابة منك يرجى الدراسة، موضوع حول المعلومات لجمع االستبانة هذه صممت وقد

فقط العلمي للبحث إال تستخدم ال لنا ستقدمينها التي المعلومات بأن لك ومؤكدين تعاونك، لك . شاكرين

ة/ :الباحث

.........................

وأهدافه البحث :وصففي تساعد سوف شأنها من التي األعمار، مختلف في النساء على استبيان توزيع إلى الدراسة تهدفوفقا العظام بهشاشة لإلصابة معرضة عمرية فئة أكثر النساء تجعل بدورها التي الخطر عوامل تحديد , لفحص دم عينة أخذ يتم سوف كما عمرية مرحلة كل في لها تتعرض التي وهرمونية جسدية لتغيرات

( الهرمونات ( نسبة لتحديد الظهر ألسفل أو الورك للحوض أشعة وصورة دال وفيتامين االستروجينهذه بين العالقة وتحديد العظام هشاشة مرض تشخيص في تساعد سوف التي العظام كثافة ونسبة

نابلس مدينة في النساء بين ومقارنتها االختباراتالدراسة هذه عن الناتجة :الفوائد

االعمار مختلف في النساء بين العظام وكثافة دال وفيتامين االستروجين هرمون نسبة قياس النساء بين العظام هشاشة حدوث في المساعدة الخطر عوامل وتحديد كشف عظام دكتور الى أحالتها يتم سوف العظام بهشاشة المشاركات أحد اصابة الى تشير نتائج اي

والفيتامين , االستروجين لفحص بالنسبة وكذلك الصغيرة االيدي جمعية في العالج لتلقي مختص

الجمعية في نسائية دكتورة الى تحويلها يتم سوف دال الدراسة في المشاركة في يرغب من لكل مجانا مؤمنة االشعة وصورة الدم عينة فحص تكاليف

, النساء من عينةاخرى اخذ يتم فسوف االنسحاب قررت او البحث هذا اإلشراكفي رفضك حالة فيالمشتركة : موافقة

اسئلتي على االجابة تمت البحث،ولقد هذا من والغرض المحتوى وفهمت هذااالستبيان قرأت . لقدPage 127 of 129

, , الباحثين , ان اعلم وأني العلمي البحث هذا في المشاركة على اوافق مختارة حرة فأني لذلك وفقا

, شئت متى البحث هذا من االنسحاب في الحق ولي وقت اي في اسئلتي عن باإلجابة يقومون سوفالتاريخ المشتركة توقيع

Page 128 of 129

Annex V (Approval of funding)

Page 129 of 129